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“Eugen Bleuler (who in 1911 coined the word ‘schizophrenia’) once said that in the 
end his patients were stranger to him than the birds in his garden. But if they're 
strangers to us, what are we to them?” (Greenberg, 2009) 
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1  I n t r o d u c t i o n  
 
Evidence from the Global Burden of Disease Study in 2010 suggests that schizophrenia, 
especially in its acute form, is one of the top ten public health concerns and the mental illness 
with the highest disability weights world-wide (Salomon et al., 2012). The introduction of 
antipsychotics during the ‘50s of the last century contributed significantly to the reduction of 
acute symptoms as well as to the prevention of relapses (Leucht et al., 2012). About 70% of 
patients with schizophrenia in the acute phase of illness show remission of positive symptoms 
(Dixon, Lehman, & Levine, 1995). The WHO concludes that antipsychotic drug treatment is 
highly effective in reducing positive symptoms in schizophrenia, while negative symptoms 
commonly remain unchanged (Barbato, 1998), leaving behind patients that do not benefit from 
antipsychotic drug treatment. Those so-called ‘non-responders’ do not achieve recovery or 
remission and are left with residual symptoms of significant functional relevance. Looking 
closer at responders vs. non-responders, the extant evidence suggests limited therapeutic effects 
of antipsychotics to positive symptoms such as delusions, hallucinations, and thought disorder 
in a substantial proportion of patients (Crow, 1980; Falkai et al., 2015). However, although 
positive symptoms better respond to medication, in approximately 25-30% positive symptoms 
prevail and thus become treatment-resistant and persistent. Keefe et al. (1987) point to exactly 
those cases of chronic schizophrenia that create great social burden and economic cost. They 
report for 1983 that although only 5% of the psychiatric population were patients with 
schizophrenia, they accounted for almost one third of the total social expenditure of mental 
illness.  
Among positive symptoms, auditory verbal hallucinations (AVH) are one of the most common 
and characteristic symptoms of schizophrenia as approximately 50% of patients diagnosed with 
schizophrenia experience life-time AVH (Vauth & Stieglitz, 2007). Again, a subgroup of 25-
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30% experiences chronic AVH despite antipsychotic medication. Treatment-refractory AVH 
are associated with enormous distress and high risk of suicide (Falloon & Talbot, 1981). It may 
lead to severe functional impairment, feelings of hopelessness and powerlessness, self-harm  
and substance misuse (Mind in Camden, 2012). 
Since the last decade research has focused on early manifestations and disease process despite 
the subgroup of chronic voice-hearers whose therapy refraction causes major distress and 
affects their lives substantially (Vauth & Stieglitz, 2007). It should, therefore, be clear that 
treatment-refractory AVH are highly in need of fundamental research. To date, the underlying 
mechanism and pathophysiology of the phenomenon are still largely unknown. So far, the 
neuroscientific state of evidence regarding AVH in schizophrenic patients points to 
morphological changes and abnormal network connectivity in the brain. Multiple neuronal 
systems seem to be involved, i.e., networks that essentially subserve language, attention, and 
executive control (see chapter 2.2.2 on neurobiological abnormalities). To achieve a 
comprehensive understanding a combination of detailed registration of clinical symptoms as 
well as multimodal structural and functional neuroimaging is mandatory. Therefore, the present 
thesis used a combined approach to record functional resting-state networks (RSN) as well as 
experimentally activated neuronal systems to investigate a potential association between 
functional neuroimaging data, clinical symptoms, and specific cognitive processes.   
 
The aim of the present thesis is to link the field of neurobiology with (neuro-)psychology 
thereby closing knowledge gaps with respect to AVH in patients suffering from schizophrenia. 
As outlined above, there is a clear need for a better understanding of causal mechanisms to 
translate this knowledge into improved treatment interventions. I would like to share my work 
and findings with the interested reader outside the academic context as well. Therefore, I will 
consider the technical terms as demanded by scientific convention and discourse as well as the 
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requirements of a doctoral thesis. However, by doing so, I nevertheless want to balance 
appropriate use of technical terms with simple expression.  
 
For clinical information and diagnostic criteria, the present study relies on the ICD-10 published 
by the WHO. The ICD-10 is used internationally and represents the most important guide for 
classification and diagnosis of (mental) illnesses in Germany. Furthermore, it must be noted 
that the following discussion regarding hearing voices refers to AVH in the course of a 
schizophrenic disorder. AVH are phenomena that can occur in up to 15% of the healthy 
population throughout lifetime according to the Continuum Model of Psychosis (Badcock & 
Hugdahl, 2012). However, research data suggests significant differences between AVH heard 
by healthy individuals compared to those experienced by patients with schizophrenia, e.g., 
frequency, valence, and sense of control (Honig et al., 1998; Powers, Kelley, & Corlett, 2017). 
Therefore, the discussion is limited to the latter.  
If not mentioned otherwise explanations apply both to males and females. 
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2  T h e o r e t i c a l  a n d  e m p i r i c a l  b a c k g r o u n d  
 
The intention of the present thesis is to elucidate the neuroscientific knowledge gap regarding 
AVH in patients suffering from schizophrenia. Therefore, the undertaken study is to be 
classified as fundamental research aiming to link functional neuroimaging data with clinical 
symptoms and specific cognitive processes. This chapter reviews the theoretical and empirical 
background and serves as a guide for the interested reader. First, schizophrenia as mental 
disorder is specified in detail including core symptoms, disease course and impact, followed by 
explanatory models to provide a common understanding. Subsequently, the focus shifts to AVH 
in schizophrenia describing known neurobiological deficits and related cognitive models. 
Thereafter, currently recognized and scientifically validated treatment options for 
hallucinations are presented. The theoretic framework concludes with the derived research 
questions to be answered and corresponding hypotheses.    
 
2.1 Schizophrenia 
The World Health Organization (WHO) defines schizophrenia as a heterogeneous and severe 
mental disorder that is characterized by a varying degree of dysfunction in cognition, 
perception, affect, motivation as well as the sense of self (2016). Most prominent are psychotic 
experiences, such as hearing voices or delusions, which may result in the inability to grasp the 
extent of reality and may thus lead to depressive and anxious symptoms and concurrent 
behavior such as social withdrawal and self-neglect. Associated malfunctions include 
concentration and attention, content and formal thought, perception, intentionality as well as 
emotions and psychomotility (Falkai, 2008).  
In the acute stage of illness patients often lose touch with reality, the ability to reason, and the 
ability to cope with the requirements of everyday life (Bäuml, 1994). Acute illness severity is 
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associated with poor insight, i.e., schizophrenic patients often are entirely controlled by their 
abnormal and pathological perceptions (Klaas et al., 2016). By the time the psychotic 
experiences recede insight is most often regained (Jorgensen, 1995). Normally, consciousness 
is unaffected as well as the general intellectual ability despite potential cognitive deficits (World 
Health Organization, 2013). In accordance with that, the extant evidence does not clearly 
suggest progressive decline in neuropsychological abilities but rather certain deficits in 
cognitive functioning as trait-marker (Özgürdal & Juckel, 2008). 
The following Table presents the diagnostic criteria formulated by the WHO. These are the 
criteria used in clinical practice internationally as well as in the process of study inclusion and 
validation of diagnosis. As a side note should be mentioned that the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) published by the American Psychiatric Association (APA) 
and the International Statistical Classification of Diseases and Related Health Problems (ICD) 
by the WHO hold comparable diagnostic criteria for the diagnosis of schizophrenia (Jansson, 
Handest, Nielsen, SÆbye, & Parnas, 2002). The difference in time criterion between ICD-10 
(1 month) and DSM-IV (6 months) still results in high concordance between the two diagnostic 
systems (Jansson et al., 2002; Wciorka et al., 1998). With the development of DSM-5 came 
three changes whose impact on clinical practice seems to be negligible, too: (1) two Criterion 
A symptoms are required instead of one, (2) one of them having to be hallucinations, delusions 
or disorganized speech, and (3) the subtypes were eliminated (Tandon, 2014). The diagnostic 
criteria proposed by the WHO use the patient’s self-reported symptoms as well as clinical 
evidence established by a mental health professional through detailed history taking, 
psychopathological assessment and clinical observation.  
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Table 1 
General criteria for schizophrenia 
F20.0- F20.3 General criteria for schizophrenia of the subtypes paranoid, hebephrenic, catatonic, 
and undifferentiated 
 
G1. The normal requirement for a diagnosis of schizophrenia is that a minimum of one very clear 
symptom (and usually two or more if less clear-cut) belonging to any one of the groups listed 
under 1. or symptoms from at least two of the groups referred to as 2. should have been clearly 
present for most of the time during a period of 1 month or more. 
 
1. At least one of the following characteristics: 
a. Thought echo, thought insertion or withdrawal or thought broadcasting 
b. Delusions of control, influence, or passivity, clearly referred to body or limb 
movements or specific thoughts, actions or sensations; delusional perception 
c. hallucinatory voices giving a running commentary on the patient's behavior, or 
discussing the patient among themselves, or other types of hallucinatory voices 
coming from some part of the body  
d. Persistent delusions of other kinds that are culturally inappropriate and 
completely impossible, such as religious or political identity, or superhuman 
powers and abilities (e.g. being able to control the weather, or being in 
communication with aliens from another world); 
 
2. Or at least two of the following characteristics: 
a. Persistent hallucinations in any modality, when accompanied either by fleeting or 
half-formed delusions without clear affective content, or by persistent over-
valued ideas, or when occurring every day for weeks or months on end. 
b. breaks or interpolations in the train of thought, resulting in incoherence or 
irrelevant speech, or neologisms 
c. catatonic behavior, such as excitement, posturing, or waxy flexibility, negativism, 
mutism, and stupor; 
d. "negative" symptoms such as marked apathy, paucity of speech, and blunting or 
incongruity of emotional responses, usually resulting in social withdrawal and 
lowering of social performance; it must be clear that these are not due to 
depression or to neuroleptic medication; 
 
G2. Exclusion criteria 
1. If patients meet criteria for a manic episode (F30) or a depressive episode (F32), too, 
criteria listed under G1.1. and G1.2. need to be emerged previously. 
2. The disorder cannot be attributed to an organic brain disorder (in the sense of F00-F09) 
or an alcohol- or substance intoxication (F1x.0), an addiction disorder (F1x.2) or a 
withdrawal syndrome (F1x.3, F1x.4). 
Note. Derived from ICD-10 English version (World Health Organization, 1992), rearranged meeting the outline 
of the German version (World Health Organization, 2013) 
 
Those unfamiliar with schizophrenia often use various related concepts synonymously that 
share similar symptoms or the same word stem providing the possibility of confusion. 
Therefore, to clearly distinguish related terms, those must be defined properly:  
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• Psychosis. Any severe mental illness characterized by impairment in reality testing, often 
featuring delusions and hallucinations. The term psychosis is often used synonymously with 
schizophrenia. However, psychosis is an umbrella term for all psychotic disorders of which 
schizophrenia is one (Bäuml, 1994).   
• Paranoia. A mental illness that is characterized by delusions of persecution; another name 
for delusional disorder (Colman, 2006). 
• Schizophreniform disorder. A mental illness with psychotic symptoms meeting the 
criteria for schizophrenia but not meeting the time criterion of symptoms being present at 
least 1 month (Colman, 2006; World Health Organization, 2013). 
• Schizoaffective disorder. A mental illness with episodes of simultaneous affective and 
psychotic symptoms that are both clinically relevant (World Health Organization, 2013). 
Due to its high overlap with affective disorders as well as schizophrenia its reliability is 
subject to ongoing debate (Santelmann, Franklin, Busshoff, & Baethge, 2015). 
• Paranoid personality disorder. A personality disorder characterized by an enduring 
mistrust, exaggerated sensitivity to insult, and the tendency to twist the seen and 
experienced into hostile and threatening constructions. The consequence is often 
quarrelsome behavior in order to carry their point and have their will (World Health 
Organization, 2013). 
• Schizotypal personality disorder. A personality disorder characterized by an enduring 
pattern of eccentric behavior as well as thought disorders and perceptual distortions similar 
to those seen in schizophrenia, often accompanied by a tendency to social withdrawal with 
marked discomfort in close personal relationships. Criteria for schizophrenia must not have 
been fulfilled at any time (Colman, 2006; World Health Organization, 2013). 
• Schizoid personality disorder. A personality disorder characterized by an enduring and 
unambiguous lack of need and desire for close personal relationships. Persons concerned 
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have a preference for fantasy and solitary behavior and show a restricted range of emotional 
expression and in experiencing happiness (Colman, 2006; World Health Organization, 
2013).  
 
2.1.1 Clinical core symptoms 
As mentioned previously, schizophrenia is a very heterogeneous disorder with great variability 
in symptoms. That is, two patients suffering both from schizophrenia may vary substantially in 
symptom patterns.  
Schizophrenia symptoms can be grouped into three categories: positive symptoms, negative 
symptoms, and cognitive symptoms. 
 
Positive symptoms  
Positive symptoms are thought to occur in addition to or as an exaggeration of normal thoughts 
and perceptions. Such symptoms predominate in the acute phase of the illness. In general, they 
respond effectively to antipsychotic medication. For a substantial proportion of patients, 
however, positive symptoms persist over time and thus become chronic. Positive symptoms 
include thought disorder, behavioral agitation, delusions, hallucinations, self-disturbance, 
passivity and alien control phenomena (Bäuml, 1994).  
 
Negative symptoms 
The term ’negative symptoms’ indicates that there is a kind of deficiency in behaviors that are 
normally present in the general population as well as in the affected individual in a healthy 
condition. They can be thought of as an impairment in ‘normal experiencing’ that was available 
prior to the illness. For the most part negative symptoms occur during prodrome or remission 
but may also be present simultaneously with positive symptoms. Negative symptoms include 
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emotional blunting, incongruity of emotional responses, paucity of speech, lack of motivation, 
and social withdrawal. 
 
Cognitive deficits 
In a recent article reviewing research findings regarding cognitive impairment in schizophrenia 
Keefe and Harvey (2012) outline that “although cognition is not a formal part of the current 
diagnostic criteria for schizophrenia [and therefore neither a positive nor a negative 
symptom][…][it] is a core feature of the illness and not simply the result of the symptoms or 
the current treatments of schizophrenia” (p. 12). Reports show that as many as 75-80% of 
schizophrenic patients have cognitive deficits that exceed clinical significance (Keefe et al., 
2004). The individual cognitive profiles, however, seem to be very heterogeneous (Pfueller, 
Roesch-Ely, Mundt, & Weisbrod, 2010). They concern various cognitive domains with 
prominent deficits found in higher-order cognitive domains such as executive functioning, 
memory (short-term, long-term as well as working memory) and learning, as well as lower-
order cognitive functions such as attention and speed of processing (Reichenberg et al., 2009). 
Cognitive deficits are “present at the beginning of the first psychotic episode, […] are stable 
over time, largely independent of positive symptomatology, and partly independent of 
medication treatment” (Frommann et al., 2011, p. 862). A reduction in cognitive capacity is 
even present in patients before the initial manifestation of psychotic symptoms (Pfueller et al., 
2010).  
 
2.1.2 Epidemiology and disease course 
The WHO (2016) estimates a lifetime prevalence of schizophrenia of 1% and about 29 million 
affected individuals worldwide. Schizophrenia typically begins in late adolescence or early 
adulthood, first onset mostly developing between puberty and the age of 35 (Falkai et al., 2015). 
A second peak incidence affecting roughly 25% of patients is to be found at the age of 40-50 
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and called late onset (Eissa, Hassan, Hwedi, & Khalil, 2013). Schizophrenia affects both women 
and men equally (Hahlweg & Dose, 1998), however, men fall ill earlier in comparison to 
women (Bäuml, 1994). That is, men show the peak incidence in the early twenties while women 
have it in their late twenties (Barbato, 1998; Hahlweg & Dose, 1998).  
Disease onset can be acute and very dramatic in which psychotic symptoms develop within 
days or weeks, but more often it is a much more subtle and longer-lasting, on average five years, 
gradual process of prodromal phase with unspecific symptoms that precede the overt psychotic 
illness (Gaebel & Wölwer, 2010). Those prodromal symptoms vary between individuals and 
may include reduced concentration and attention, social withdrawal, neglect of body hygiene, 
and inflated mistrust (Rodewald, 2010) as well as increased noise sensitivity, general 
restlessness and nervousness, sleeplessness, irritability, loss of interest, and depression (Bäuml, 
1994). They cause high distress in early/acute stages of disease development already. However, 
these behavioral changes are not specific to schizophrenia and are therefore often not correctly 
recognized but rather misinterpreted as temporary crisis or symptoms of other psychological 
disorders (Gaebel & Wölwer, 2010). They are recognized as early symptoms of schizophrenia-
spectrum disorders in retrospect only.  
The acute stages of illness vary in length and number of episodes. In 1972 Bleuler formulated 
his famous ‘rule of thirds’ which states that about a third of patients with schizophrenia achieve 
complete remission after one or a few episodes, another third has repeated episodes with a mild 
degree of impairment and the last thirst develops a severe and chronic disability (Rodewald, 
2010). This classification, however, appears to be oversimplified and outdated, since the course 
of disease exhibits great intra- and interindividual variability. The course of disease is reflected 
in the fifth character of the ICD-10 code and can be further classified as continuous, episodic 
with progressive deficit, episodic with stable deficit, episodic remittent, incomplete remission, 
complete remission, or other (World Health Organization, 1992). While a quarter of patients 
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concerned with schizophrenia experience only one episode of illness - the numbers vary 
between 10-25% (Bäuml, 1994; Gaebel & Wölwer, 2010) - most patients develop multiple 
episodes with different degrees of impairment. Of those approximately 20-30% exhibit an 
unfavorable clinical course with multiple recurrences and chronic residual symptoms with 
increasing disability (Barbato, 1998; Gaebel & Wölwer, 2010). This residual phase is 
accompanied by negative symptoms such as social withdrawal, affective blunting, lack of 
motivations and interest (Hahlweg & Dose, 1998).  
 
2.1.3 Impairment and burden 
More than a century after Bleuler coined the term schizophrenia approximately half of affected 
patients still have a poor outcome (Falkai, 2008; Falkai et al., 2015). Studies suggest that about 
40% of male and 25% of female patients with schizophrenia actually experience chronic 
impairment of moderate to severe extent (Barbato, 1998). Not surprising, schizophrenia is 
among the most burdensome and cost-intensive illnesses worldwide although it has a relatively 
low prevalence rate. According to the Global Burden of Disease Study (World Health 
Organization, 2004), schizophrenia causes such a vast amount of disability that it accounts for 
1.1% of the total disability-adjusted life years (DALYs) and 2.8% of years lived with disability 
(YLDs). In the World Health Report (World Health Organization, 2001), schizophrenia is even 
ranked as the 8th leading cause of DALYs and 3rd leading cause of YLDs for the group aged 
15-44 years (Rossler, Salize, van Os, & Riecher-Rossler, 2005). Disability affects the essential 
domains of emotional experience and human behavior, particularly social functioning in 
various areas such as self-care and body hygiene, occupational performance, but also 
functioning in interpersonal relationships as well as in a broader social context (Barbato, 1998; 
Falkai, 2008) As a consequence, only one third of patients are employed in the primary labor 
market and are able to maintain a stable relationship (Falkai, 2008; Falkai et al., 2015). In 
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addition, life expectancy is reduced by approximately 10 years. Schizophrenia is no fatal 
disease per se, but death rates of affected patients are twice as high as those in the healthy 
population due to exorbitantly higher lifetime risk of suicide  (times 12, Barbato, 1998; 
DeVylder & Hilimire, 2015).  
Estimates of economic cost of schizophrenia range between 1,6-2,6% of total health care 
expenditures (Barbato, 1998). Germany‘s economic burden of schizophrenia ranged between 
€9.63 billion and €13.52 billion in 2008 (Frey, 2014). 
Apart from the financial burden of a schizophrenic disorder to society, there is substantial strain 
on relatives (Rossler et al., 2005), e.g., financial burden and emotional distress due to unusual 
behavior and social/emotional withdrawal (Barbato, 1998).  
 
2.1.4 Explanatory models 
Stephan and colleagues (2009) point out that “schizophrenia has largely remained an enigma. 
Despite all research efforts, there is still no consensus about its exact pathophysiological 
mechanisms” (p. 509). Marcotte and colleagues (2001) go on to remark that “current research 
into schizophrenia has remained highly fragmented, much like the clinical presentation of the 
disease itself.” (p. 395). Accordingly, several hypotheses that were formulated in an attempt to 
explain the symptomatic cause and separate pathogenic mechanisms of schizophrenia are 
introduced in the following before presenting one of the more prominent theories, the integrated 
sociodevelopmental-cognitive model by Howes and Murray (2014). 
 
Dopamine hypothesis 
The dopamine (DA) hypothesis was formulated in the 1970s based on two findings: First, the 
clinical effectiveness of antipsychotics works by blocking DA receptors. Second, drugs that 
work on the DA system, e.g., amphetamine, have the potential to induce psychotic symptoms 
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(Creese, Burt, & Snyder, 1976; Seeman & Lee, 1975). The theory aims to explain the 
pathogenic mechanism of schizophrenia by suggesting DA dysfunction to be the underlying 
cause of positive symptoms. Initially, the emphasis was on increased presynaptic DA synthesis. 
More specific, greater DA release was thought to be associated with more severe psychotic 
symptoms (Howes & Murray, 2014). The mechanism is illustrated in Figure 1. 
 
Figure 1. Dopamine hypothesis of schizophrenia.  
According to the DA hypothesis of schizophrenia, an increased release of DA into the synaptic gap caused by a 
dysregulation of the dopaminergic system is thought to be underlying the development of psychotic symptoms. 
DA=dopamine.  
 
Although the DA hypothesis provides a reliable model for positive symptoms it does not 
account sufficiently for negative or cognitive symptoms in schizophrenic patients (Steeds, 
Carhart-Harris, & Stone, 2015). 
 
Neurodevelopmental hypothesis 
The neurodevelopmental hypothesis tries to explain the origin of schizophrenia by recognizing 
prenatal and perinatal hazards as major influence, see Figure 2. Factors that have been shown 
to contribute to the development of schizophrenia are prenatal or perinatal risk factors such as 
birth complications, low birthweight, and in-utero infection, abnormal early childhood 
development, i.e., motor delay, social alterations, and cognitive impairments, as well as brain 
structural alterations, i.e., ventricular enlargement, grey matter reductions, and white matter 
disruption (Howes & Murray, 2014). Within the neurodevelopmental hypothesis DA 
dysregulation is regarded as a manifestation of the presynaptic dysfunction and is considered 
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as secondary to the interaction between primary neurobiological lesions and maturational 
processes (Howes & Murray, 2014). 
 
Figure 2. Neurodevelopmental hypothesis of schizophrenia.  
The figure illustrates the suggested pre- and perinatal factors that influence the dopaminergic system leading to an 
exaggerated release of DA into the synaptic gap resulting in psychotic symptoms. DA=dopamine. 
 
Cognitive model 
The biology of schizophrenic disorders is explained by the dopamine and developmental 
hypotheses. However, they do not help sufficiently to understand the individual symptoms. 
Cognitive models of schizophrenia focus on psychological mechanisms in an attempt to 
elucidate this knowledge gap (Frith, 2015). Cognitive models propose that schizophrenic 
patients are cognitively biased due to deviations in neurodevelopment and, therefore, are more 
likely to misperceive certain internal and external information. Those models draw a vicious 
circle in which stress intensifies existing cognitive disturbances such that the processed content 
is perceived as threatening to the self. The search for a plausible explanation for the deviant 
experiences is then, again, biased by cognitive appraisal processes resulting in the faulty 
judgement that these experiences are externally driven. In this way, paranoid delusions for 
example are presumed to be formed (Howes & Murray, 2014). For a flow chart diagram 
illustrating the mechanisms see Figure 3. 
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Figure 3. Cognitive model of schizophrenia.  
Neurodevelopmental hazards and childhood adversities in combination with various psychological mechanisms 
and cognitive biases thought of as triggering and maintaining factors for psychotic symptoms. 
 
Integrated sociodevelopmental-cognitive model 
Although cognitive models represent a major advancement in understanding the development 
of schizophrenia and symptom occurrence in specific the dopamine hypothesis and 
neurodevelopmental hypothesis have not been integrated satisfactorily. It is for this reason that 
the integrated sociodevelopmental-cognitive model has been postulated by Howes and Murray 
(2014). The integrated sociodevelopmental-cognitive model takes into account the underlying 
biological determinants and combines those with childhood risk factors, biased cognitive 
schemas, and acute environmental stress (see Figure 4). In their model Howes and Murray 
suggest that a combination of developmental changes secondary to variant genes, early risk 
factors for neural development, and childhood adversities sensitize the dopamine 
neurotransmitter system. Consequently, this process leads to excessive presynaptic synthesis 
and release of dopamine. This results in a bias in individual’s cognitive schema that is used to 
process stimuli towards paranoid interpretation. Thus, the amendment to previous cognitive 
models appears in the more detailed explanation of the development of cognitive biases by 
adding diverse social and biological abnormalities that subsequently lead to dopamine 
sensitization and thereby to an abnormal information processing. The integrated 
sociodevelopmental-cognitive model goes on to explain that subsequent stress triggers the 
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sensitized dopamine synapse resulting in dysregulated dopamine release. As a consequence, 
stimuli are misattributed and misinterpreted. As the resulting delusions and hallucinations in 
turn cause further stress, a vicious cycle is established, and eventually hardwired through 
repeated dopamine dysregulation (Howes & Murray, 2014). 
 
Figure 4. The integrated sociodevelopmental-cognitive model of schizophrenia.  
Expanding upon the previous explanatory models, the sociodevelopmental-cognitive model combines biological, 
social and cognitive factors that are thought of to result in psychotic symptoms. The figure illustrates the 
mechanisms of action and interactions with regard to the underlying biological determinants, childhood risk 
factors, biased cognitive schemas, and acute psychosocial stress. DA=dopamine. 
  
25 
2.2 Auditory verbal hallucinations (AVH) in schizophrenia 
In former times, AVH were sometimes considered as ‘message from god’. Today some 15% of 
the healthy population at times hear voices (Laroi et al., 2012). Still, hallucinations are now 
frequently regarded as abnormal and a sign of mental illness, especially when embedded in a 
multitude of other symptoms that accompany manifest psychosis (see also section 2.1.1). 
Hallucinations are a core symptom and therefore characteristic of schizophrenia and 
schizophrenia-spectrum disorders. They are defined as perceptual experience with the 
impression of a real perception in the absence of a provoking stimulus to the sensory organ 
(Colman, 2006). Hallucinations can occur in any modality of perception, i.e., optical, olfactory, 
gustatory, tactile, and auditory with about two-third of patients experiencing one or the other 
hallucination (Andreasen & Flaum, 1991; Gaser, Nenadic, Volz, Buchel, & Sauer, 2004). 
Prevalence data of hallucinations in schizophrenic patients found in literature indicate that 
auditory hallucinations are the most common with about 50-80% (Slade & Bentall, 1988), 
followed by visual hallucinations with 15%, and tactile hallucinations with 5% (Cutting, 2007). 
Most often auditory hallucinations are manifested in the form of auditory verbal hallucinations 
(AVH), i.e., ‘hearing voices’, but might include music, ringing, animal sounds, clicks, and 
humming as well (McCarthy-Jones, Trauer, et al., 2014). Basically, AVH can be distinguished 
between commenting, commanding, and conversing voices, and further differentiated in their 
number of voices, voice identity (male/female), perceived location (internal/external), 
frequency and duration, loudness (from whispering to shouting), clarity (from mumbling to 
clear sounds), complexity (from single words to phrases), and content (positive/negative, often 
insulting) (Laroi et al., 2012; McCarthy-Jones, Trauer, et al., 2014). Typically, AVH involve 
personal degradation, abusive terms and threats without the person concerned perceiving any 
control over onset or end of the experience making them feel as intrusions and thus leading to 
high levels of distress (Laroi et al., 2012). Although the symptoms respond to antipsychotic 
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medication in the majority of cases, 25-30% of AVH persist and become chronic (Shergill, 
Murray, & McGuire, 1998). Those chronic, persistent hallucinations are then called ‘treatment-
refractory’. Treatment-refractory persistent AVH not only cause great distress but are also 
associated with an unfavorable prognosis, reduced quality of life and economic costs (for more 
details go to www.gbe-bund.de).  
 
2.2.1 Treatment concepts for AVH 
Schizophrenia is a mental illness that is not curable but treatable. Therefore, treatment goals 
include symptom reduction, acquisition of coping skills, stability and according relapse 
prevention as well as reintegration (Rossler et al., 2005). According to the WHO, 50% of people 
coping with schizophrenia do not receive treatment although different treatment concepts are 
available that can be provided at community level  (World Health Organization, n.d.). As the 
causes of the development of schizophrenia are still largely unknown, treatments are mostly 
symptomatic in that they focus on the reduction and/or elimination of symptoms. Available 
treatments include antipsychotic medication, psychoeducation, psychotherapy, various 
psychosocial support programs and in some instances both non-invasive and invasive brain 
stimulation techniques (Sommer et al., 2012).  
 
Pharmacotherapy 
The introduction of chlorpromazine in 1952 by Delay and Deniker and its potential use as 
antipsychotic medication provided a significant improvement in symptomatic treatment and 
relapse prevention (Ban, 2007; Leucht et al., 2012). Pharmacotherapy in patients with 
schizophrenia is directed at specific symptoms rather than at the disorder itself. Therefore, the 
main goals of psychopharmacological treatment are symptom reduction and control as well as 
relapse prevention. Antipsychotic medication is the treatment of choice for schizophrenia in 
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general and hallucinations in specific (Finzen, 2009; Sommer et al., 2012). Antipsychotic drugs 
are capable of inducing a rapid decrease in hallucination severity as well as a general 
improvement of acute symptoms (Sommer et al., 2012). However, as mentioned previously, 
pharmacotherapy can fail to improve AVH leaving them to remain in a clinically significant 
severity in approximately 25% of patients with schizophrenia (Davis, Schaffer, Killian, Kinard, 
& Chan, 1980; Shergill et al., 1998). In specific, treatment-resistance is a failure to demonstrate 
an adequate response with an adequate treatment which is defined as two antipsychotics of 
different classes with sufficient dosage and duration (Berman, Narasimhan, & Charney, 1997). 
In cases of treatment-refractory symptoms, clozapine poses another treatment option that 
renders the potential of symptom reduction (Kane, 1992). If clozapine also falls short of an 
effect, it is called clozapine-resistance. 
 
Cognitive-Behavioral Therapy 
The objective of psychotherapy, i.e., Cognitive-Behavioral Therapy (CBT), in medicated 
patients with residual AVH is much more multi-faceted than that of pharmacotherapy alone. It 
includes the development of a common understanding of the problem, destigmatization and 
normalization, challenging negative beliefs and developing coping strategies, as well as the 
acceptance of unchangeable conditions, thereby trying to reduce symptoms or at least making 
them feel more controllable. CBT for AVH, thus, does not aim to reduce severity and frequency 
of hallucinations in the first place. Rather, CBT is based on a cognitive approach as it assumes 
that AVH occur more often because of their emotional valence (Lincoln, 2014) consequently 
targeting the way hallucinations are appraised. Specifically, CBT aims at changing appraisals 
of AVH that makes them appear more powerful, e.g., omnipotence, omniscience, and 
malevolent. Furthermore, CBT involves the development of new coping strategies. As a 
consequence, targeting emotional appraisal may not only reduce the experienced severity and 
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related distress of AVH (Sommer et al., 2012) but symptom frequency as well. In addition, 
CBT involves behavioral changes in that it requests confrontation with the voice, spoken 
content and associated thoughts (Lincoln, 2014) as well as testing of alternative ways to deal 
with particular situations (Sommer et al., 2012) thereby reducing behavioral avoidance. 
Furthermore, relapse prevention presents a major treatment goal for CBT (Klingberg & Wittorf, 
2012). 
Research results indicate that CBT for AVH in schizophrenia is indeed helpful in changing 
patients’ beliefs about their voices (Pinkham, Gloege, Flanagan, & Penn, 2004), reducing 
conviction in the power of and compliance to commanding voices (Penn et al., 2009; Trower et 
al., 2004), reducing symptom distress (Newton et al., 2005; Wykes, Parr, & Landau, 1999), 
increasing the number and effectiveness of coping strategies (Wykes et al., 1999), and in 
improving overall symptom severity over the treatment phase (Newton et al., 2005) as well as 
after a follow-up interval of 12-months (Penn et al., 2009). In addition, recurrence rate is 
reduced by 54% due to CBT (Wiedemann & Klingberg, 2003). This, however, is not specific 
for AVH but refers to the general recurrence of psychotic symptoms in schizophrenia. In 
contrast, Wykes et al. (2005) who compared group CBT to treatment as usual found no effect 
on AVH severity but on social functioning. Still, there were improvements in AVH in some of 
the therapy groups emphasizing the importance of therapist experienced and early treatment 
availability. To conclude, CBT may provide a significant improvement in the patients’ quality 
of life (Shergill et al., 1998). 
 
Avatar therapy 
Expanding upon the CBT-idea of directly relating to the voice, a novel and innovative 
computer-based therapy program for persistent AVH was developed. Avatar therapy is based 
on the idea that a dialogue between affected patients and their voices may facilitate a regain in 
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feeling of control (Leff, Williams, Huckvale, Arbuthnot, & Leff, 2014). In the computer 
program, the patient is instructed to construct an avatar with a face and voice that approximates 
the entity he hears as AVH. With the therapist’s encouragement the patient enters a dialogue 
with the digital representation of his hallucination. The avatar is under the control of the 
therapist who is speaking with the patient from an adjacent room with a control panel. Over the 
course of six 30min sessions the avatar progressively changes its character from formerly 
negative to appreciative, supportive, and, most importantly, more controllable. A copy of the 
dialogue is handed out to the patient afterwards (Leff et al., 2014). 
A first study examining avatar therapy in comparison to treatment as usual found significant 
reductions of AVH frequency and intensity post-treatment (Leff, Williams, Huckvale, 
Arbuthnot, & Leff, 2013). The follow-up assessment at three month showed further reductions 
in AVH frequency and intensity as well as additional reductions in depressive symptoms. A 
first randomized controlled trial study investigating the effectiveness of avatar therapy for 
treatment-refractory AVH compared the former to supportive counselling in schizophrenia and 
affective disorders with psychotic symptoms (Craig et al., 2018). Their results support the 
evidence that avatar therapy is effective in reducing AVH severity and frequency. This is of 
clinical importance as patients often suffer for many years from persistent AVH and the 
procedure seems to be cost- and time-saving. 
 
Brain stimulation techniques 
Different brain stimulation techniques are available as a treatment for otherwise treatment-
refractory auditory verbal hallucinations. The goal of such kind of treatment in schizophrenic 
patients with AVH is symptom reduction.  
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Transcranial Direct Current Stimulation (tDCS). Transcranial Direct Current Stimulation 
(tDCS) is a non-invasive neurostimulation technique inducing weak electric currents via two 
electrodes that are placed directly on the individual’s scalp. The electric current flows from the 
anode (positive charge) to the cathode (negative charge) (Mondino et al., 2015) resulting in 
modulation of neuronal activity of the desired brain areas. tDCS is a rather new technique 
(Brunelin et al., 2012), hence recommendations regarding treatment frequency and duration are 
based on recent research studies. Brunelin and colleagues (2012) administered ten sessions over 
five days in 30 patients with schizophrenia. With inhibitory stimulation over the left temporo-
parietal cortex and excitatory stimulation over the left dorsolateral prefrontal cortex they 
achieved a significant reduction in severity of treatment-refractory AVH that lasted up to three-
month follow-up. First reviews on this subject suggest that improvement may not be limited to 
hallucinatory symptoms but may be effective for negative and cognitive symptoms as well 
(Agarwal et al., 2013). Additionally, tDCS has only few side effects (Brunelin et al., 2012) 
rendering it a promising treatment option for persistent AVH in schizophrenia. 
 
Repetitive Transcranial Magnetic Stimulation (rTMS). Repetitive Transcranial Magnetic 
Stimulation (rTMS) is a non-invasive and painless brain stimulation technique that makes use 
of repetitive electromagnetic pulses send through a stimulator coil. The coil is placed just above 
the individual’s scalp, directly above the desired stimulation area. The electromagnetic pulse 
then penetrates the underlying brain tissue up to a depth of 3cm resulting in an intracranial flow 
of current and neuronal activation (Aleman, Sommer, & Kahn, 2007; Barker, Freeston, 
Jalinous, & Jarratt, 1987; Sommer et al., 2012). rTMS treatment consists of daily sessions for 
several consecutive days up to weeks (Aleman et al., 2007) depending on the severity of 
symptoms. The side effects are generally mild (Slotema, Blom, Hoek, & Sommer, 2010) 
without neurocognitive impairment to be expected (Aleman et al., 2007; Sommer et al., 2012). 
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For treating AVH in schizophrenia the left temporo-parietal cortex seems to be a promising 
target area as meta-analyses provide support for moderate to good therapeutic effects (Kubera, 
Barth, Hirjak, Thomann, & Wolf, 2015; Slotema et al., 2010; Sommer et al., 2012). However, 
not all features of AVH seem to benefit equally (Freitas, Fregni, & Pascual-Leone, 2009). The 
study by Hoffman’s group (2013) found an effect on frequency but not on severity of AVH, 
while the meta-analysis by Slotema and colleagues (2010) found rTMS to improve severity of 
AVH. Then again, Fitzgerald et al. (2005) found an effect on the loudness of AVH but not on 
severity. In addition, the beneficial effects do not seem to be of lasting nature (approx. one 
month, Kubera et al., 2015; Slotema, Aleman, Daskalakis, & Sommer, 2012) and rTMS does 
not seem to improve positive symptoms in general (Aleman et al., 2007). 
 
Theta burst transcranial magnetic stimulation (TBS). Because treatment with rTMS is time-
consuming and shows only moderate, non-durable effects (Plewnia, Zwissler, Wasserka, 
Fallgatter, & Klingberg, 2014), theta-burst stimulation (TBS) might be a promising alternative. 
TBS is a modified rTMS-protocol with repeated application of low-intensity rTMS (Huang, 
Edwards, Rounis, Bhatia, & Rothwell, 2005). Its advantage over standard rTMS is the shorter 
application time. In the continuous TBS paradigm (cTBS), 40s of continuous 50Hz stimulation 
is applied (Huang et al., 2005) to the left (and sometimes also the right) temporo-parietal cortex 
(Plewnia et al., 2014).  
Kindler and colleagues (2013) found 10-day treatment of cTBS to be equally effective in 
reducing AVH scores than 1Hz rTMS stimulation. Koops et al. (2016) found an effect on AVH 
severity but failed to demonstrate the superiority of cTBS when compared to a placebo group. 
Plewnia and colleagues (2014) compared cTBS with a sham-control group and found both to 
be equally effective in reducing AVH severity, too. However, they report a trend towards cTBS 
(p=.077).  
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In sum, according to the studies available to date cTBS does not seem to be more effective than 
rTMS. Still, cTBS indeed seems to be a promising technique in reducing AVH and is potentially 
more attractive as treatment as its application time is much shorter.  
 
Electroconvulsive Therapy (ECT). Electroconvulsive Therapy (ECT) is usually considered 
the ‘last resort’ treatment for severe treatment-resistant schizophrenia (Folkerts et al., 2003). 
During ECT, a high electrical current is administered via electrodes attached to the individual’s 
scalp to induce a generalized seizure. To avoid negative effects of the convulsion the procedure 
is performed under general anesthesia and muscle relaxation to prevent body spasms (Sommer 
et al., 2012). Treatment is repeated at least two times a week with a total number of ECT 
treatments of 11 on average (Lally et al., 2016). Side effects include serious cognitive 
impairments in memory performance that seem to accumulate with repeated treatment on the 
one hand and on the other hand are mostly reversible lasting up to several months (Kolb & 
Whishaw, 1996). As to treatment effects in schizophrenia, several studies show improvement 
of clinical status in general, however, the effect of ECT on AVH has not yet been shown on 
group level (Kubera et al., 2015; Sommer et al., 2012). 
 
2.2.2 Neurobiological abnormalities in AVH 
Clinical and phenomenological studies are interested in schizophrenia and in particular chronic 
and treatment-refractory AVH since decades. But not until the advent of neuroimaging 
technologies, especially magnetic resonance imaging (MRI) and computer tomography (CT) in 
the 1970s their neurobiological underpinnings could be examined.  
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Structural deviations 
Structural neuroimaging studies as well as reviews on the existing literature point to abnormal 
gray as well as white matter volume in frontal, temporal and parietal regions as potential neural 
correlates of AVH in patients prone to hallucinations (Allen, Larøi, McGuire, & Aleman, 2008; 
Gaser et al., 2004). However, the topography of volume changes varies considerably across 
studies (Allen, Larøi, et al., 2008), probably as a consequence of clinical, psychometric and/or 
methodological heterogeneity.  
Compared to non-hallucinating individuals, the hallucinating brain is consistently shown to be 
associated with a reduction in grey matter tissue in the temporal lobe (Allen, Larøi, et al., 2008), 
especially the left superior temporal gyrus (STG) including the left transverse temporal gyrus 
of Heschl, i.e., the primary auditory cortex (Gaser et al., 2004).  
Studies have repeatedly shown an inverse relationship between severity of AVH and the STG 
(Neckelmann et al., 2006). In addition, reduced grey matter volume was reported in the middle 
temporal gyrus (MTG) (Onitsuka et al., 2004), the left insula (Shapleske et al., 2002), the 
thalamus (Neckelmann et al., 2006), left and right cerebellum (Neckelmann et al., 2006), and 
posterior cingulate cortex (Upthegrove et al., 2016). Furthermore, a reduced volume is observed 
in the right dorsolateral prefrontal cortex and the left (inferior) supramarginal gyrus (Gaser et 
al., 2004). Kubera and colleagues (2014) identified an AVH-specific structural network of 
reduced gray matter volume in medial and inferior frontal, insular and bilateral temporal cortical 
regions. This network was further associated with physical characteristics of hallucinations 
such as symptom frequency, duration, and intensity. Finally, when talking about brain structural 
deviations, it is not solely about atrophy in gray matter volume but also about abnormal 
gyrification. Cortical gyrification is thought of as stable morphological feature thus 
representing early neurodevelopmental indices. Kubera et al. (2018) presented evidence for an 
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abnormal cortical gyrification in Broca’s area specific to AVH, supporting the notion of cortical 
vulnerability in key regions associated with speech and language.  
In sum, structural neuroimaging in patients with persistent, treatment-refractory AVH 
demonstrates selective changes in brain morphology. However, this kind of research neither 
allows investigating the neurofunctional dynamics of AVH nor the impact of persistent 
symptoms on cognition. 
 
Functional deviations 
Evidence from functional MRI studies stems from two distinct approaches: ‘symptom capture’ 
and ‘symptom interference’ studies. The two approaches differ in the underlying assumption of 
either measuring the hallucinatory state or trait. Symptom capture studies addressing AVH in 
schizophrenia aim to capture neuronal activity of ‘spontaneous’ hallucinations during the 
scanning process (state). This is often done when the brain is otherwise ‘at rest’, so-called 
resting-state conditions. Those studies point to an increase in the blood oxygen level–dependent 
(BOLD) signal suggesting an increase in neuronal activity during AVH in temporal to frontal 
language-related areas (Upthegrove et al., 2016). In specific, increased blood flow is observed 
in the superior and middle temporal gyrus (Lennox, Park, Medley, Morris, & Jones, 2000), 
including transverse gyrus of Heschl matching the primary auditory cortex (Dierks et al., 1999), 
and Wernicke’s area/secondary auditory cortex (Zmigrod, Garrison, Carr, & Simons, 2016). 
Further activity is reported regularly in the inferior frontal gyrus, i.e., Broca’s area (Aleman, 
2014; McGuire, Shah, & Murray, 1993). Other cortical areas that have been shown consistently 
to activate during AVH include (para-) hippocampal regions, the thalamus, the basal ganglia, 
the anterior cingulate cortex, and the cerebellum (Shergill, Brammer, Williams, Murray, & 
McGuire, 2000; Zmigrod et al., 2016). Meta-analyses suggest a strong left lateralization (Jardri, 
Pouchet, Pins, & Thomas, 2011). In sum, evidence from symptom capture studies suggest AVH 
35 
in schizophrenic patients to be correlated with frontotemporal language-related perceptual, e.g. 
Heschl’s gyrus and Wernicke’s area involved in speech perception and interpretation, and 
motor areas, e.g. Broca’s area involved in speech production, as well as with medial temporal 
areas associated with verbal memory (Jardri et al., 2011; McGuire et al., 1993). To a lesser 
extent, AVH are also associated with activity in the anterior cingulate cortex which is involved 
in attentional processes (Allen, Larøi, et al., 2008; McGuire et al., 1993). 
In contrast, symptom interference studies assume that AVH bound neural resources which are, 
therefore, less available to other mental operations. These studies use task-based designs 
involving material that is thought to make use of similar neural correlates as AVH. It follows 
the hypothesis of a decrease in neural activation patterns in hallucinating individuals. Those 
activation decreases may, then, reflect processes attributable to AVH generation (trait). A recent 
review addressing findings from symptom interference studies point to decreases in anatomical 
and functional connectivity of language-related brain areas (Curcic-Blake et al., 2017). In 
specific, decreased neural activity in the left STG, left MTG, anterior cingulate cortex (ACC), 
and left premotor cortex activity seems to be associated with AVH (Curcic-Blake et al., 2017; 
Kuhn & Gallinat, 2012).  
However, research evidence shows some inconsistencies regarding the specific brain areas of 
altered activation when incorporating both, symptom capture and symptom interference studies: 
The meta-analysis by Kompus, Westerhausen, and Hugdahl (2011), exemplary, assumes what 
they call a ‘paradoxical’ brain activation regarding AVH. They point to an increased activation 
in the left primary auditory cortex and in the right rostral prefrontal cortex while at rest, and 
decreased activation in the presence of an external auditory stimulus in the same brain areas. In 
contrast, Kühn & Gallinat observed a dissociation between an activation in bilateral inferior 
frontal gyrus, postcentral gyrus, and left parietal operculum and decreased activation in the left 
STG as well as MTG, ACC, and left premotor cortex activity. 
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Dysfunctional neuronal connectivity 
In addition to pathophysiology associated with hearing voices in schizophrenia, emerging 
evidence points to disturbances in functional connectivity (Gaebel & Zielasek, 2008). 
Functional connectivity is defined as the temporally and statistically correlated pattern of 
activity of two or more anatomically distinct brain regions (Friston, 1994). It follows that 
functional ‘dysconnectivity’ is an abnormal interaction between multiple brain areas (Friston 
& Frith, 1995). Wolf et al. (2011) examined functional resting-state networks (RSN) in 
schizophrenic patients with chronic AVH in a preliminary work for the current project. The 
goal was the exploration of neural network connectivity in four networks previously identified 
to be associated with AVH: (1) speech processing, (2) attention, (3) executive control and (4) 
the so-called ‘default mode network’ (DMN) (Allen, Laroi, McGuire, & Aleman, 2008; 
Thomas, Rossell, & Waters, 2016).  
The network comprising language processing covers left fronto-temporo-parietal areas 
(Hugdahl, Loberg, & Nygard, 2009). In specific, it consists of Broca's and Wernicke's areas 
(Smith et al., 2009) as well as anterior insula, posterior inferior frontal cortex, and anterior 
inferior frontal cortex (Gitelman, Nobre, Sonty, Parrish, & Mesulam, 2005). The attentional 
network is located in the right fronto-parietal lobe and comprises areas in the intraparietal sulcus 
and inferior parietal lobule including temporo-parietal junction, supplementary and pre-
supplementary motor areas, anterior insula, ventral occipital cortex, and dorsolateral prefrontal 
cortex (Fox et al., 2005; Markett et al., 2014). The executive control network “covers several 
medial–frontal areas, including anterior cingulate and paracingulate” (Smith et al., 2009). The 
DMN is a network of brain areas that are active at rest and deactivated during attention-
demanding tasks. It comprises posterior medial and lateral cortices including precuneus and 
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posterior cingulate, and bilateral inferior–lateral–parietal and ventromedial frontal cortex 
(Smith et al., 2009; Williamson, 2007).  
Wolf and colleagues (2011) found an association between AVH and functional connectivity in 
the speech network as well as in networks associated with attentional and executive 
performance. Within the language-related RSN, increased connectivity in bilateral temporal 
regions including left STG and bilateral MTG and decreased connectivity in the cingulate 
cortex was associated with AVH. Within the attention and executive control RSNs patients with 
AVH exhibited abnormal connectivity in the precuneus and right lateral prefrontal areas, 
respectively. Regarding AVH symptom severity, correlations of the extent of hallucinatory 
symptoms and functional connectivity of the left ACC, left STG and right lateral prefrontal 
cortex were demonstrated. However, they did not confirm DMN dysconnectivity. In contrast, 
Alderson-Day et al. (2016) reported altered DMN connectivity in addition to altered functional 
connectivity involving executive control, salience and sensory networks. The above-mentioned 
neural networks associated with AVH in schizophrenia are illustrated in Figure 5.  
A recent review focusing on functional connectivity in AVH summarizes the research evidence 
as primarily lacking consistent replication (Curcic-Blake et al., 2017). The strongest evidence 
involves the left temporal cortex including the primary auditory cortex, STG and the left 
temporo-parietal junction (TPJ). However, regarding STG both elevated and reduced functional 
connectivity was observed across different studies. Furthermore, research results implicate an 
involvement of the DMN in the development of AVH (Alderson-Day, McCarthy-Jones, & 
Fernyhough, 2015). This hypothesis is plausible given the relevance of the DMN for self-
reference and self-attribution (Buckner, Andrews-Hanna, & Schacter, 2008). 
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Figure 5. AVH-related resting-state networks (RSN).  
This figure provides a pictorial overview of four neural networks that are thought to be associated with AVH in 
schizophrenia: language, attention, executive control, and DMN (from upper left to bottom right). With kind 
permission, illustration taken from Wolf et al. (2011)1, p. 369. 
 
In sum, research on functional connectivity in schizophrenic patients with chronic AVH has 
highlighted various regions and functional networks including areas associated with language 
and DMN. Gaser et al. (2004) suggest that AVH “are not associated with a single regional 
                                                 
1 Reprinted from Wolf, N. D., Sambataro, F., Vasic, N. …  Wolf, R.C.:  Dysconnectivity of multiple resting-state 
networks in patients with schizophrenia who have persistent auditory verbal hallucinations, Fig. 1. Canadian 
Medical Association Journal 2011;36(6):366-74. © Canadian Medical Association (2011). This work is protected 
by copyright and the making of this copy was with the permission of the Canadian Medical Association Journal 
(www.cmaj.ca) and Access Copyright. Any alteration of its content or further copying in any form whatsoever is 
strictly prohibited unless otherwise permitted by law. 
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deficit. Rather, several nodes of a more complex circuitry might be involved. Changes in 
primary auditory cortex and temporo-parietal areas might be at the core of this abnormality, 
and together with prefrontal deficits this could result in deficient frontotemporal interaction” 
(p. 95). 
 
2.2.3 Linking cognitive models of AVH with neural deviations  
To account for the heterogeneous phenomenology of auditory verbal hallucinations several 
neurocognitive models have been proposed. They are based on findings with regard to common 
features of AVH, e.g., internally generated but attributed externally, clear perceptual quality 
with sense of reality, experienced loss of control, and often accompanied by emotional valence. 
Four major theoretical models have been proven useful to some extent in understanding the 
nature of AVH in patients with schizophrenia: aberrant auditory imagery, intrusive memories, 
misattribution of inner speech, and the predictive processing framework. 
 
Auditory imagery 
One of the earliest explanations for AVH can best be described as far-fetched ‘chance 
discovery’. In 1883, Galton started an inquiry among members of the Fellows of the Royal 
Society in order to investigate their “hereditary faculties” (Galton, 1883, p. 1). Galton’s 
objective had been to identify those characteristics that render those individuals ‘superior’ to 
the rest of humankind to promote the evolution of men. In his inquiry, he found a relationship 
between the experience of particularly vivid mental imagery and hallucinations in ‘great man 
in history’ whom he calls “visionairies” (Galton, 1883, pp. 112-128). Consequently, the vivid 
imagery account of AVH was born. Studies trying to scientifically examine an association 
between vividness of auditory imagery and proneness to AVH in patients with schizophrenia 
usually failed except for one (Seal, Aleman, & McGuire, 2004). Mintz and Alpert (1972) found 
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a positive correlation between the presence of hallucinations and vividness of auditory imagery 
whereas the majority of studies found no such relationship or even reduced mental imagery in 
hallucinating patients (Seitz & Molholm, 1947). Summarizing the current state of evidence, 
there seems to be no robust association between auditory imagery and auditory hallucinations 
in schizophrenia. 
 
Aberrant memory processing 
The presence of AVH in schizophrenia has also been linked to intrusive memories in general 
(Badcock & Hugdahl, 2012). In specific, it is argued that AVH result from a process of an 
inability to inhibit the intrusive activation of memories on the one hand (Curcic-Blake et al., 
2017) and an impairment in monitoring the source of memories on the other hand (Seal et al., 
2004). It is thought of as unintended memory activation out of context. Indeed, research results 
indicate that hallucinating individuals have poor inhibitory control and suffer from frequent 
intrusive memories (Badcock & Hugdahl, 2012) providing evidence for the first part of the 
aberrant memory account. The defective inhibitory system offers a way to explain the 
experienced involuntariness and loss of control that comes with AVH (Badcock & Hugdahl, 
2012). Furthermore, the often negative and derogative content of AVH could be explained in 
terms of memories of childhood traumatic events that are frequent among schizophrenic 
patients, and particularly in those with hallucinations. Verbal hallucinatory content that can be 
linked to the experience of traumatic events often involve, for example, the voice of the former 
abuser that commands self-harm. This phenomenon has been also referred to as ‘voices as 
traumatic experiences’ (Upthegrove et al., 2016). In the context of trauma, it is important to 
point out whether these are true hallucinations or so-called ‘pseudohallucinations’, defined as 
hallucination-like sensory experience that are recognized as not being caused by any sensory 
source and that occur in posttraumatic stress disorder, for example (Wearne & Genetti, 2015).  
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On a neurobiological level, if inhibition as well as memory processes are implicated in AVH, 
areas involved include the prefrontal cortex (PFC) for inhibition, the hippocampus for memory, 
the amygdala for emotional processing, the putamen for translation of memory into conscious 
language experience as well as auditory networks (Curcic-Blake et al., 2017). In support, 
immediately prior to AVH a hippocampal deactivation has been observed (Curcic-Blake et al., 
2017) while a hyperactivation is apparent during hallucinations (Upthegrove et al., 2016) 
suggesting an involvement of the hippocampus and amygdala. In addition, PFC dysfunction 
has been constantly associated with AVH in schizophrenia (Badcock & Hugdahl, 2012) 
supporting the theory of intrusive memories. 
However, despite the appeal of the aberrant memory model of AVH conclusive evidence of a 
source memory deficit in schizophrenia that is specific for self-generated material is lacking. In 
contrast, a current review summarized the existing literature as suggesting “that the nature of 
memory deficit observed amongst those with prominent positive symptoms is not a problem 
with identifying the source of memories but with remembering what they said or imagined in 
the first place” (Seal et al., 2004, p. 55, italics from original). Additionally, the model does not 
account for the more severe and complex auditory hallucinations (Upthegrove et al., 2016). 
 
Self-monitoring of inner speech model 
A phenomenological key aspect of AVH is the experience’s origin outside the self, which holds 
true for ‘thought echo’ as well (Hugdahl et al., 2007). This property has inspired a series of 
research and theories regarding a neurocognitive model of AVH as misattribution of inner 
speech to an external source due to defective self-monitoring (Frith, 2015). I will subsume the 
different accounts regarding source- and self-monitoring and their extensions under this 
subtitle. Frith and Done (1988) suggested that internally generated stimuli, e.g., inner speech, 
are connected to planned or willed action. Subsequently, Frith (2015) argues that inner speech 
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will be misinterpreted as externally generated if the sense of one’s own intention is not 
experienced properly. Thus, central to the theory of impaired self-monitoring in AVH is not the 
inner speech per sé but that patients fail to recognize that it is self-generated. In sum, a 
dysfunction in the source- or self-monitoring system of intentional processes leading to a 
mismatch between the predicted and actual sensory consequences is suggested to cause the 
external attribution bias observed in AVH (Allen, Larøi, et al., 2008).  
Research results in cognitive psychology do indeed find that schizophrenic patients in general 
exhibit a bias in that they tend to attribute their inner experiences to external sources (Shiraishi 
et al., 2014). Furthermore, hallucinating subjects in particular demonstrate higher error rates in 
identifying their own voice and erroneously misattribute their own speech to an external agent 
more often compared to non-hallucinating patients (Seal et al., 2004). Moreover, recent meta-
analyses provide strong evidence for an impaired self-recognition (Waters, Woodward, Allen, 
Aleman, & Sommer, 2012) as well as externalizing bias (Brookwell, Bentall, & Varese, 2013) 
in patients with schizophrenia and particularly those with AVH.  
At a neuronal level, according to the model, areas of interest include the temporal cortex 
involved in inner speech perception, medial prefrontal cortex, posterior cingulate cortex, and 
precuneus for processing information about self (Heatherton, 2011) as well as the PFC that 
facilitates monitoring processes. The PFC dysfunction was already mentioned earlier relating 
to the aberrant memory model of AVH and may explain why hallucinations are experienced as 
involuntary. The dysfunction of the right dorsolateral PFC in combination with a volume 
reduction in the left hemisphere auditory and speech perception areas may underlie the inability 
to inhibit and correctly attribute inner speech (Gaser et al., 2004). In addition, a series of studies 
using a task that requires subjects to monitor their own speech found an atypical pattern of 
temporal, parahippocampal, and cerebellar cortical activation in hallucinating patients (Seal et 
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al., 2004). A very recent review article on the subject matter summarizes the evidence as 
follows:  
Auditory cortex responses are suppressed during vocalization. Connectivity between 
frontal (perhaps Broca’s area) and temporal areas (auditory cortex) has been suggested 
to be responsible for the auditory cortical suppression, as the degree of connectivity 
between these areas during talking is related to the degree of suppression. This 
communication could signal the arrival of self-generated sensations (Curcic-Blake et 
al., 2017, pp. 3-4).  
Taken together, these findings support the theory that AVH reflect abnormal activation of 
auditory pathways (Lennox et al., 2000). However, several researchers in the field agree that 
the model is insufficient in that it falls short of accounting for the complexity and severity of 
AVH as well as certain aspects of their phenomenology, e.g., multiple voices, third-person talk 
(Curcic-Blake et al., 2017; Fovet et al., 2016; Upthegrove et al., 2016). 
 
Predictive processing framework 
Following on from the above-mentioned shortcomings of the self-monitoring account, 
Wilkinson (2014) expressed a need for explanation on the emerging challenges of auditory 
phenomenology and varieties of AVH. The first challenge entails the transformation into 
hallucinations that often have the acoustical properties of someone else speaking, e.g., pitch 
and timbre. Yet, inner speech is generally lacking these characteristics (Cho & Wu, 2013). The 
second one emphasizes the heterogeneity of AVH, e.g., first-person vs. second- or third-person, 
and single or multiple voices, which, too, cannot be accounted for by self-monitoring processes 
exclusively. Wilkinson realized that these AVH-specific phenomena can be accounted for 
within a predictive processing framework (PPF, Fletcher & Frith, 2009). According to the PPF, 
to explain input the brain generates hypotheses about its cause and based on these determines 
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subsequent predictions about expected input. It settles for one hypothesis rather than another if 
“it better minimises prediction error” (Wilkinson, 2014, p. 146, italics from original). This can 
be done either by altering predictions to fit the incoming input or by altering the ‘world’ 
(oneself, including bodily posture and attention) to fit the predictions. Thus, within the 
framework of PPF, AVH are seen as ‘abnormalities in predictive processing’ due to defective 
precision weighting. More specific, heightened attention on, for example, ongoing thoughts or 
memories causes erroneous amounts of prediction error that needs to be accounted for by 
adopting the (faulty) hypothesis of perception (Wilkinson, 2014).  
Evidence for this account stems from studies examining perceptual illusions (in which 
expectancies play a crucial role) that usually find those not working for schizophrenic patients, 
e.g., the Hollow Mask Illusion (Schneider et al., 2002) or the McGurk Effect (Pearl et al., 2009) 
suggesting a breakdown in perceptual and predictive processing. Furthermore, the prediction 
error signal is thought to be modulated by the neurotransmitter dopamine which is of particular 
importance in schizophrenia (Corlett, Taylor, Wang, Fletcher, & Krystal, 2010). Neuroimaging 
studies of prediction error dysfunction suggest involvement of the midbrain, i.e., the basal 
ganglia, the prefrontal cortex, especially the anterior cingulate cortex and the orbitofrontal 
cortex, and the hippocampus (Corlett et al., 2010). And indeed, hallucinations in schizophrenia 
seem to be associated with dysfunction in these and other brain regions: “[…] a reasonably 
robust pattern of implicated regions has emerged including the […] inferior frontal gyrus […]; 
[…] the parahippocampal gyrus and hippocampus […]; the middle and superior temporal gyri 
[…]; and the thalamus” (Tracy & Shergill, 2006, p. 651). Moreover, limbic and paralimibic 
regions, including the cingulate gyrus, as well as orbitofrontal cortex have been demonstrated 
to show abnormal activation in hallucinating individuals (Silbersweig et al., 1995) supporting 
the notion that prediction error dysfunction may underlie AVH. Figure 6 presents a pictorial 
overview of the involved brain areas.  
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Figure 6. Predictive processing framework.  
Arrows illustrate the direction of influence; the dashed blue line illustrates an increase in excitation. With kind 
permission, illustration taken from Curcic-Blake et al. (2017), p. 4; detail. 
 
Summarizing the above explanations, each presented cognitive model of AVH in schizophrenia 
builds upon flaws and serious challenges faced by the aforementioned account. At present, the 
predictive processing framework is best able to explain a vast amount of research findings, 
whether neurocognitive or phenomenological. However, as Powers, Kelley, and Corlett (2016) 
put it: “precision weighting awaits more extensive empirical investigation in humans” (p. 4). It 
should be further noted that the neuroimaging evidence presented for each model, in fact, 
overlaps in large parts and thus, for itself, does not favor any of the presented theories. 
 
2.3 Summary 
AVH are defined as a sensory experience of hearing voices in the absence of a corresponding 
external stimulus with a compelling sense of reality. They are one of the core symptoms of 
schizophrenia. About 50-80% of patients with schizophrenia experience AVH (Andreasen & 
Flaum, 1991; Cutting, 2007; Shergill et al., 1998), such as commenting, commanding, and 
conversing voices. Although in a majority of cases ‘hearing voices’ can be sufficiently treated 
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by antipsychotic medication, 25-30% do not respond to pharmacological treatment and thus 
persist and become chronic (Davis et al., 1980; Shergill et al., 1998). Other treatment options 
include CBT and various brain stimulation techniques. Treatment-refractory AVH, obviously, 
cause significant psychosocial impairment and a reduction in quality of life. Therefore, AVH 
have attracted extensive clinical and phenomenological research for several decades. With the 
introduction of neuroimaging techniques such as the MRI and CT in the 1960s and ‘70s the 
focus has shifted to investigate the neurobiological underpinnings of AVH. Consequently, this 
development has led to a better understanding of this subjective phenomenon. In the last few 
years, however, research has focused on early manifestations and disease process despite the 
subgroup of chronic voice-hearers whose therapy refraction causes major distress and affects 
their lives substantially (Vauth & Stieglitz, 2007). It should, therefore, be emphasized that 
treatment-refractory AVH are highly in need of fundamental research. To date, the precise 
neurocognitive and neurobiological mechanisms contributing to AVH occurrence are still 
largely unknown with partly divergent models and different studies providing inconsistent 
results. So far, the neuroscientific state of evidence regarding AVH in schizophrenic patients 
points to morphological and functional changes in frontal, temporal and parietal regions as well 
as abnormal network connectivity in the brain. Multiple neuronal systems seem to be involved, 
i.e., language, attention, and executive control. In addition, research results accumulate 
indicating that AVH on a neurocognitive level are associated with “impaired verbal self-
monitoring and impaired memory for own speech; an abnormal influence of top-down 
processing on perception; and an externalizing response bias” (Seal et al., 2004, p. 60). 
However, the overall trend in schizophrenic research is a failure to find a positive correlation 
of cognitive deficits with positive symptoms (Keefe & Harvey, 2012). These inconsistencies 
suggest that the extent of cognitive deficit associated with AVH in schizophrenic patients, 
especially in comparison with non-AVH patients is still largely a matter of debate.  
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To conclude, persistent treatment-refractory AVH are associated with circumscribed neuronal 
deficits and potentially with cognitive deficits. However, the patients’ heterogeneity as well as 
unsuccessful attempts to reproduce some of the published findings leave questions on the exact 
relationships between functional and structural aberrancy as well as psychopathology at the 
symptom level. Therefore, Thönnessen and Mathiak (2008) advocate an integrated 
neuroimaging method that combines dynamic and connectivity dimensions with anatomical 
information to achieve a functional understanding of these dysfunctions.  
 
2.4 The present study  
As the present thesis is part of a larger DFG-funded project (WO 1883/2-1) the derived research 
questions and associated hypotheses present only a part of the full spectrum of potential 
research focus. This doctoral thesis focuses on the potential association between functional 
neuroimaging data, clinical symptoms, and specific cognitive processes regarding treatment-
refractory and persistent AVH in schizophrenia. To achieve a comprehensive understanding a 
combination of a detailed registration of clinical symptoms as well as multimodal structural and 
functional neuroimaging is advantageous. Therefore, the present thesis used a combined 
approach to record functional RSN and experimentally activated neuronal systems as well as 
psychometric data and neuropsychological test results. The majority of studies so far are limited 
to a comparison between a patient group of schizophrenic patients with persistent AVH (pAVH) 
and a healthy control group (HC). Few compare with a clinical control group comprising 
schizophrenic patients without AVH additionally (nAVH). For example, to date, not a single 
study has been conducted to compare the cognitive profile of hallucinating individuals to that 
of non-hallucinating patients and healthy control participants. The aim of this thesis is to 
complement the existing literature in that regard by comparing two patient groups (with and 
without AVH) with a healthy comparison group. Thus, the present cross-sectional study used a 
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between-subjects factor design with group (hallucinating, non-hallucinating, and healthy 
individuals) as naturally occurring condition that could not be randomized. 
A symptom interference approach was chosen, in which AVH are thought to compete with 
auditory stimuli and verbal processing for neuronal resources (Plaze et al., 2006). The alertness 
task and n-back task were chosen as functional MRI (fMRI) activation paradigms; the alertness 
task measuring intrinsic and phasic alertness and the n-back task measuring verbal working 
memory (WM). Both paradigms were chosen, inter alia, because of their auditory/verbal nature: 
The alertness task possesses an auditory component by using an auditory stimulus as preceding 
warning tone while the n-back task makes use of verbal processing by using letters as visual 
stimuli. Furthermore, both paradigms were successfully used in the past  (Wolf et al., 2012), 
the underlying cognitive domains (Kathmann & Reuter, 2008; Wolf & Walter, 2008) as well as 
neural correlates and involved networks are well described (Muller & Knight, 2006; Sturm & 
Willmes, 2001) and show a well-documented association with schizophrenia (Wolf et al., 2011; 
Wolf, Vasic, Höse, Spitzer, & Walter, 2007; Wolf, Vasic, & Walter, 2006), rendering them 
attractive for study in relation with AVH. In addition, deficits in WM are thought to underlie 
the genesis of AVH (Jenkins, Bodapati, Sharma, & Rosen, 2018). Not only that, the n-back has 
been extensively studied internationally in the context of schizophrenia (Glahn et al., 2005).  
The present study tries to answer the question whether AVH are associated with common or 
distinct neural activation patterns in frontal, parietal and temporal areas compared to two control 
groups, i.e. one clinical population and a healthy control sample. Furthermore, it tries to 
elucidate the question of spatial correspondence between these functional activation patterns 
and performance on the task, neuropsychological measures of cognitive functioning, as well as 
psychopathology as defined by symptom-specific psychometric measures.  
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Considering the extant functional neuroimaging data on AVH in schizophrenia and expanding 
on previous findings as described above, based on the presented research questions the 
following hypotheses will be examined: 
 
1. Both fMRI activation paradigms lead to different functional neural activation patterns in 
pAVH compared to nAVH as well as HC.  
a. Specifically, for the alertness task, it is predicted that pAVH will show a specific 
attenuated activation in brain areas where attentional processes are required, i.e. the 
right fronto-parietal attention network comprising the intraparietal sulcus, the inferior 
parietal lobe, and the dorsal premotor cortex as well as in the auditory cortex and 
supplementary motor area (Fox et al., 2005). According to the aforementioned symptom 
interference studies the alertness task is hypothesized to exert reduced neural activation 
in the attention network of pAVH when compared with both control groups.  
b. For the n-back task, it is predicted that patients with AVH in relation to both comparison 
groups show attenuated activation in a network commonly associated with WM tasks, 
comprising the DLPFC, the VLPFC, and the inferior parietal lobule (Wolf et al., 2009). 
Again, in accordance with assumptions of symptom interference studies the n-back task 
is thought to lead to reduced neural activation in the WM network in pAVH when 
compared with both control groups. 
 
2. In patients with AVH, the extent and location of neural dysfunction related to hallucinating 
will interfere with neural function, i.e. attention and WM elicited by specific cognitive tasks, 
i.e. alertness and n-back task.  
a. For the alertness task, it is predicted that for hallucinating individuals there is a negative 
correlation between brain activation and behavioral performance as operationalized in 
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terms of reaction times and false negative rates. That is, the lower the neural activation 
in the attention network due to it being ‘bound’ by AVH, the higher the reaction times 
and the false negative rates; thus, the poorer the performance. 
b. For the n-back task, in patients with AVH, it is predicted that there is a negative 
correlation between brain activation and behavioral performance as operationalized in 
terms of reaction times and error rates (false negatives and false positives). In 
accordance with the identical hypothesis for the alertness task, reduced neural activation 
in the corresponding networks is thought to be associated with higher reaction times and 
error rates. 
 
3. AVH-related neural activation on both paradigms is associated with neuropsychological 
performance off-line, i.e. outside the MRI scanner. That is, hallucinations interfere with 
other ongoing cognitive processes, beyond alertness and verbal WM. The rationale of this 
prediction is best described in terms an ‘extended symptom interference’ assumption, i.e. 
that neural substrates associated with symptom occurrence will interfere with several 
cognitive functions apart from what can be investigated with fMRI. Therefore, it is predicted 
that hallucinating subjects exhibit worse performance in tasks demanding attention, spatial 
and verbal WM and executive function compared to controls and non-hallucinating patients. 
 
4. AVH-related brain regions exhibiting task-related neural dysfunction are predicted to be 
negatively correlated with psychopathology. Following and expanding upon the findings 
by Kubera et al. (2014), it is predicted that physical characteristics, such as loudness, 
intensity and spatial location are associated with a dysfunction of temporo-parietal regions 
whereas affective and cognitive dimensions are associated with cingulate and dorsolateral 
prefrontal cortex function, respectively. Reduced neural activation in pAVH is predicted to 
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be associated with higher scores in physical characteristics, in accordance with the basic 
concept of the symptom interference approach. 
 
Since the statistical null hypothesis does not postulate any difference between the groups, the 
representative null hypothesis for all alternative hypotheses is mentioned at this point: The 
groups do not differ on any of the postulated comparisons and, furthermore, the group has no 
effect on any measurement variable. 
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3  M e t h o d s  
 
The current chapter comprises a detailed description of the research questions and according 
hypotheses as well as the methodology used for the purpose of scientific investigation. First, 
the process of study enrollment, including inclusion and exclusion criteria of participants is 
described followed by a description of the studied sample. Subsequently, the procedure each 
individual has undergone is outlined. Thereafter, the used measurements, divided in 
subchapters comprising fMRI, applied neuropsychological assessment, and psychiatric 
interview, are presented in detail. Finally, the statistical procedures for the data analysis are 
depicted.  
The illustrations were created using Paint Version 6.1 (Microsoft Windows 7), Microsoft 
Publisher and Excel (v14.0.7015.1000, Microsoft Office Professional Plus 2010) as well as 
MRIcron version 6 6 2013.  
 
3.1 Participants 
3.1.1 Inclusion/exclusion criteria 
Inpatients and outpatients aged 18-65 years were considered if the attending psychiatrist  had 
established a clinical ICD-10 F20 schizophrenia diagnosis that was confirmed by the research 
psychiatrist based on clinical impression and semi-structured interviews. All patients were 
assessed using the Positive and Negative Syndrome Scale (PANSS) and Brief Psychiatric 
Rating Scale (BPRS). Furthermore, study inclusion was bound to the absence of an organic 
and/or mental disorder, neurological disease or head injury as well as any signs of mental 
retardation, substance abuse within the last six weeks and substance dependence (except 
nicotine) in the past year, and the absence of any type of suicidal ideation. 
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The patient group was divided into individuals experiencing AVH and individuals who did not 
experience such symptoms for at least 12 months prior to neuropsychological assessment and 
MRI scanning, based on detailed information regarding clinical history, current symptoms as 
well as test scores (PANSS-P item 3, BPRS item 12). In particular, patients were assigned to 
the pAVH group if they reported hearing voices daily and scored equal to or higher than 4 on 
item 3 (hallucinations) of the PANSS Positive Symptom Scale and 5 or higher on item 12 
(hallucinations) of the BPRS. The inclusion criteria are summarized in Table 2.  
 
Table 2 
Inclusion criteria 
 inclusion criteria 
general (1) Subjects are between 18 and 65 years of age. 
(2) Subjects have no neurological disorder. 
(3) Subjects have no history of unconsciousness or coma related to head 
trauma. 
(4) Subjects do not fulfill the criteria for substance abuse or -dependence 
during the last 12 months. 
(5) Subjects have no contraindication for MRI-scanning2. 
schizophrenic patients 
with AVH 
(1) Subjects are diagnosed with schizophrenia according to ICD-10 
criteria. 
(2) Subjects have sufficient insight into the illness. 
(3) Subjects have persistent auditory verbal hallucinations daily. 
(4) AVH remain persistent despite unsuccessful medication with at least 
two antipsychotics. 
schizophrenic patients 
without AVH 
(1) Subjects are diagnosed with schizophrenia according to ICD-10 
criteria. 
(2) Subjects have sufficient insight into the illness. 
(3) Subjects did not have any AVH during the last 12 months. 
healthy controls (1) Subjects do not have any psychological or neurological disorder. 
(2) Subjects have a negative family history of neurological or mental 
disorders. 
 
                                                 
2 General MRI contraindications include for example metal parts in or on the body such as piercings or tattoos 
with magnetic color particles, implants, coronary stents, insulin pumps, pacemakers, and pregnancy. 
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Healthy control subjects were matched on age, gender, and education on a group-wise level. 
They were excluded from participation when self-reports revealed a neurological and/or mental 
disorder, a positive family history of neurological and/or mental disorder or past and/or present 
substance abuse or dependence excluding nicotine.  
 
3.1.2 Subject enrollment 
During the term of the present research study 135 inpatients with a diagnosis of schizophrenia 
were identified. In addition, nine outpatients volunteered for participation coming to a total of 
144 potential study participants regarding the patient group. Of those, 15 patients presented 
with acute symptoms, had no insight into their illness or had restricted cognitive abilities, 13 
had physical or mental conditions that were incompatible with the study design (epileptic 
seizures, stroke, other brain injuries, claustrophobia or non-removable metal parts in or on the 
body), in seven patients the diagnosis of schizophrenia could not be confirmed, nine had a 
recent history of substance abuse or dependency, two patients had communication/ language 
comprehension problems, one did not meet inclusion criteria for one of the two groups, i.e., the 
patient did not experience AVH at the moment but did experience AVH during the last 12 
months, and one out-patient lived outside of the recruitment area leaving 96 potential study 
participants. Of those ten were lost due to discharge or relocation and 29 refused to take part in 
the study so that 57 of the initial 144 patients could be included. With drop-outs during the 
study due to discomfort in the MRI scanner (n=3), and again, disconfirmed diagnosis (n=2) and 
unfulfilled inclusion criteria for the two groups (n=2) 50 individuals remained. This gives a 
response rate of 34.72% among patients. Of these 50 patients, 3 had to be excluded due to left-
handedness, 13 because of missing data, 7 because of ghosting artifacts (5 for the alertness 
task), and another 4 (3) because of movement artifacts, leaving 23 (26) patients for analyses. 
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Patients Healthy Controls 
 
 
Figure 7. The enrollment process for patients with schizophrenia and control participants.  
 
Enrollment process for both, patients with schizophrenia (including hallucinating as well as 
non-hallucinating individuals) and healthy control subjects, is presented in Figure 7. 
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3.1.3 Sample description 
A total of 44 participants participated in the current study, schizophrenic patients: n=26 and 
healthy controls: n=18. Participant’s mean age was M=34.57 years (SD=12.31; range 18-57) 
and 59.09% (male to female ratio 26:18) were male. Group comparisons were performed using 
analyses of variance (ANOVA) for three groups as well as independent-samples t-tests for 
numerical data for two groups and the Chi-square test for continuous data. Chlorpromazine 
equivalents (CPZ) were calculated for both patient groups according to Woods and 
supplemented by Leucht (Leucht, Samara, Heres, & Davis, 2016; Leucht et al., 2015; Woods, 
2003).  Table 3 provides an overview of participants’ characteristics.  
The three groups - pAVH, nAVH, and HC - did not differ significantly in age (F(2,41)=.276, 
p>.05), gender (χ2(2)=2.764, p>.05), years of education (F(2,40)=1.915, p>.05), and fluid 
intelligence as measured with the ‘Leistungsprüfsystem’ (Horn, 1983) (F(2,41)=.290,  p>.05).  
The two patient groups did not differ on duration of illness (t(24)=-.023, p>.05), antipsychotic 
treatment dosages measured in CPZ (t(24)=1.460, p>.05), negative symptoms as measured with 
the negative symptom subscale of the Positive and Negative Syndrome Scale (PANSS) 
(t(24)=1.340, p>.05), and global symptom severity as measured with the PANSS global severity 
index (t(24)=1.405, p>.05). However, patients with and without AVH did differ in positive 
symptoms as measured with the PANSS positive symptom subscale (pAVH: M=17.43, 
SD=4.36; nAVH: M=12.0, SD=4.51), t(24)=3.105, p=.005 and overall symptomatology as 
measured with the BPRS total score (pAVH: M=44.64, SD=6.77; nAVH: M=34.75, SD=9.43), 
t(24)=3.027, p=.007. When factoring out the AVH-item, thus subtracting it from the respective 
total score, the group differences were no longer significant (PANSS-P: t(24)=1.112, p>.05; 
BPRS: t(24)=1.857, p>.05).  
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Table 3 
Demographic and clinical characteristics of the study sample 
 Group; mean (SD)  
Characteristic pAVH, n=14 nAVH, n=12 HC, n=18 p value 
age, a 32.93 (11.63) 34.08 (11.91) 36.17 (13.53) ns 
sex, male:female 10:4 8:4 8:10 ns 
education, a 13.64 (2.82) 15.5 (2.57) 15.24 (2.68) ns 
fluid intelligence, raw 29.71 (4.39) 30.92 (5.05) 29.22 (7.49) ns 
duration of illness, a 10.91 (10.98) 11.0 (8.55) - ns 
CPZ equivalents 549.71 (305.87) 380.82 (280.39) - ns 
PANSS-P 17.43 (4.36) 12.0 (4.51) - .005 
PANSS-P min AVH item 12.93 (4.29) 11.0 (4.51) - ns 
PANSS-N 17.71 (5.58) 14.25 (7.31) - ns 
PANSS-G 33.86 (6.35) 29.92 (7.74) - ns 
BPRS 44.64 (6.77) 34.75 (9.43) - .007 
BPRS min AVH item 39.79 (6.65) 33.75 (9.43) - ns 
PSYRATS emotional index 11.36 (2.341) - - - 
PSYRATS physical index 6.00 (1.569) - - - 
PSYRATS cognitive index 9.50 (2.245) - - - 
PSYRATS total 26.86 (4.312) - - - 
Note. a=years, CPZ=chlorpromazine, PANSS=Positive and Negative Syndrome Scale, PANSS-P=PANSS 
Positive symptoms subscale, PANSS-N=PANSS negative symptoms subscale, PANSS-G=PANSS global severity 
index, BPRS=Brief Psychiatric Rating Scale; fluid intelligence as measured with subtest 3 from the 
Leistungsprüfsystem; regarding the PSYRATS only the auditory hallucination subscale was used. 
 
All patients were receiving standard antipsychotic medication with a stable drug treatment 
regime for at least two weeks prior to study enrollment.  
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3.2 Measures 
The measures used in the current project can be divided as belonging to three domains: fMRI, 
neuropsychology, and psychopathology (including psychometric data). Figure 8 gives a 
pictorial overview over the used measures that will be introduced and explained in the course 
of this chapter. 
 
 
Figure 8. Overview over the used measures.  
TAP=Test for Attentional Performance, CVLT=California Verbal Learning Test, WCST=Wisconsin Card Sorting 
Test, LPS=Leistungsprüfsystem, BPRS=Brief Psychiatric Rating Scale, PANSS=Positive and Negative Syndrome 
Scale, PSYRATS=Psychotic Symptom Rating Scale, BAVQ=Beliefs About Voices Questionnaire, BCIS=Beck 
Cognitive Insight Scale, EHI=Edinburgh Handedness Inventory. A detailed description of all procedures and 
measures follows throughout the chapter. With kind permission for free usage, illustrations taken from 
www.pixelio.de from Dieter Schütz, I-vista, and birgitH. 
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3.2.1 Functional magnetic resonance imaging – fMRI 
Magnetic resonance imaging (MRI) is a neuroimaging procedure. It is based on the physical 
principle that protons have an intrinsic ‘spin’ and are therefore magnetic. The MRI procedure 
makes use of a combination of static and high-frequency magnetic fields that selectively excite 
protons in the examined tissue. While the static magnet field results in a parallel alignment of 
the protons, the high-frequency pulse provokes a transverse magnetization. After switching off 
the high-frequency pulse, the transverse magnetization decreases so that the protons return to a 
parallel alignment to the static magnetic field. This process can be measured. FMRI is based on 
the different magnetic properties of oxygenated and non-oxygenated hemoglobin (Blood 
Oxygen Level Dependent, BOLD effect). Neural activity increases the local metabolism. This 
results in increased blood flow leading to regional changes in the oxygen content of the blood. 
The measurement of these changes accordingly allows conclusions about the neural activity 
(Schneider & Fink, 2013). 
Neuroimaging data were acquired in cooperation with the Department of Neuroradiology at the 
University Hospital Heidelberg, Germany. Prior to fMRI scanning, subjects received training 
in the experimental paradigms that were to be carried out in the scanner. In addition, the 
equipment was tested for appropriate functioning. Furthermore, participants received further 
MRI specific instructions by the staff and were informed about the bell to alert the technician 
in case of emergency.   
A 3 Tesla Siemens MRI Scanner equipped with a 32-channel head coil was used to collect 
whole-brain structural and functional scans. Where applicable, stimuli were presented on a 
screen behind the MRI-scanner that was visible to participants via a mirror placed above the 
coil. Scans were performed in darkness. The scanner protocol included four measurements in 
the following order: a resting-state scan, two experimental paradigms, and a structural scan. 
Participants were instructed to not fall asleep and move as little as possible during the scanning 
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process. Task-related performance measures such as reaction times were recorded using MRI-
compatible devices.   
 
Resting-state 
In the absence of external task demands, the inherent pattern of brain activity becomes 
observable. These so-called ‘resting-state fMRI’ approaches offer the potential of identifying 
brain activity at ‘rest’. Resting-state fMRI is based on the assumption that the resting brain 
always exerts a certain amount of neural background activity that can be measured by 
fluctuations in the local BOLD signal (Grodd & Beckmann, 2014). Participants were instructed 
to keep their eyes closed and to not think about anything in particular during resting-state MRI. 
The resting-state protocol lasted 6min and 44s. In this time, 200 whole brain volumes were 
recorded in a transverse (axial) orientation with a repetition time (TR) of 2000ms; echo time 
(TE)=30ms, field of view (FoV)=192mm, flip angle=90°, voxel size=3×3×3mm, 33 slices, slice 
thickness=3mm, distance factor between slices (slice ‘gap’)=33%.  
 
Activation paradigms for fMRI 
The used experimental activation paradigms (one examining alertness and one examining 
verbal WM) fall within the category of symptom interference studies. Both paradigms were 
successfully used in the past (Wolf et al., 2012), show a well-documented association with 
schizophrenia (Wolf et al., 2011; Wolf et al., 2007; Wolf et al., 2006), rendering them attractive 
for study in relation with AVH, and the underlying neural correlates are well described (Muller 
& Knight, 2006; Sturm & Willmes, 2001). 
 
Alertness task. Intrinsic and phasic alertness were assessed using a non-verbal alertness task. 
The task was programmed with Presentation® (Neurobehavioral Systems, Inc.) to match the 
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corresponding task from the ‘Test for Attentional Performance’ (TAP; Zimmermann & Fimm, 
1995) according to a description found in Wolf et al. (2012). The programming was 
accomplished with the help of Dr. Ruth Schmitt, Dr. Ruth Adam, and Dr. Stephan Walther, 
employees of the Department of General Psychiatry in 2014.  
The task is to press a button immediately after the appearance of an oblique cross on the 
otherwise black computer screen. It comprises two conditions: The first condition is meant to 
measure intrinsic alertness (IA). In the IA condition, the task is simply to press the button on 
the appearance of the visual stimulus. The stimulus is, however, presented at quasi random time 
intervals with a jittered intertrial interval (595-1495ms) and a second jitter prior to the 
appearance of the stimulus (160-1060ms) to create nonrhythmic appearance. The second 
condition is meant to measure phasic alertness (PA). In the PA condition, the oblique cross is 
preceded by a short auditory warning tone, a ‘beep’, of approximately 460hz and a fixed 
duration of 500ms. Participants were instructed to not respond with the button press until the 
oblique cross appears thereafter. Again, there was a programmed intertrial interval jitter (755-
955ms) and a pre-target jitter (200-400ms). Figure 9 outlines the procedure in visual form. 
Presentation of the visual stimulus had a fixed duration of 500ms, with a response dependent 
abortion. The conditions were presented in a block design with each block consisting of 10 
trials with duration of each trial of approximately 2,2ms and each block lasting 22s. Each 
condition was presented 4 times in a pseudo-randomized order: IA(1) – PA(1) – PA(2) – IA(2) 
– IA(3) – PA(3) – PA(4) – IA(4). Between two blocks, an interblock interval acting as baseline 
consisting of a white dot in the center of the black screen was presented for another 22s. Before 
scanning, all participants were trained offline. Task performance is recorded in terms of reaction 
times (RT) as well as hits and stimulus omissions.  
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Figure 9. Outline of the alertness task.  
A. Condition without preceding warning tone measuring intrinsic alertness, B. Condition with preceding warning 
tone measuring phasic alertness. In both conditions, the participant is instructed to reply with a button press to the 
target, ‘X’. ITI=inter trial interval, IBI=inter block interval. 
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In total, the alertness task protocol lasted 5min 56s. 160 T2*-weighted whole brain EPI images 
were acquired in an axial orientation; TR=2200ms, TE=29ms, FoV=192mm, flip angle=85°, 
voxel size=3×3×3mm, 36 slices, slice thickness=3mm, slice ‘gap’=33%. 
 
N-Back task. The n-back task (Kirchner, 1958) was used to assess verbal WM. The task was 
programmed by Dr. Jacob Lahr and provided by Dr. Elisa Scheller, both from the University 
Hospital in Freiburg, Germany. The task was adopted by Dr. Stephan Walthers to fit the 
requirements of the current project. 
During the task, participants are presented a sequence of visual stimuli, in this case letters. The 
presentation takes place one by one. White letters are presented on a black screen. The task 
demands to indicate for each individual letter if the current stimulus is the same as the one n 
trials ago. The n indicates the number of trials, e.g., 1-back asks participants to remember the 
letter one trial back. The higher the number, i.e., the more trials you must remember, the more 
difficult the task. Participants need to press the response button only for those trials where the 
stimulus matches the one n trials ago and are instructed not to respond on all other trials. Figure 
10 shows an exemplary representation of the 2-back condition. 
The task used in this project comprises a 0-back, i.e., an attention task of low-complexity, as 
well as 1-back and 2-back condition. The letters ‘A’, ‘B’, ‘H’, ‘K’, ‘T’, ‘U’, and ‘V’ were used 
as visual stimuli as they are easy distinguishable in visual appearance. The specific sequence 
of letters was presented in a pseudo randomized order.  
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Figure 10. Outline of the n-back task.  
The 2-back condition asks the participant to remember the penultimate letter and respond with a button press 
whenever the current stimulus matches the second last. 
 
Presentation of the visual stimulus had a fixed duration of 500ms, with a response-dependent 
abortion. Total trial duration including response time was fixed at 3s. No jitter was added before 
or after the stimulus presentation. The conditions were presented in a block design with each 
block consisting of 10 trials. Each condition was presented 4 times in a predefined order: 1-
back(1) – 2-back(1) – 0-back(1) – 2-back(2) – 0-back(2) – 1-back(2) – 1-back(3)  – 2-back(3) 
– 0-back(3) – 0-back(4) – 1-back(4) – 2-back(4). Before scanning, all participants were trained 
offline.  
Neuroimaging data acquisition for the n-back task included 205 T2*-weighted whole brain EPI 
images in an axial orientation; TR=2230ms, TE=30ms, FoV=192mm, flip angle=85°, voxel 
size=3×3×3mm, 36 slices, slice thickness=3mm, slice gap=20%. Task performance is recorded 
in terms of reaction times (RT) as well as hits and misses. In total, the n-back task protocol 
lasted 7min 42s. 
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Structural data 
At the end of the functional protocol, structural MRI images needed for data preprocessing were 
acquired. In specific, 192 T1-weighted images were acquired in an axial orientation; 
TR=1900ms, TE=2.52ms, FoV=256mm, flip angle=9°, voxel size=1.0×1.0×1.0mm, 192 slices, 
slice thickness=1mm, slice gap=50%. The protocol lasted 4min 26s. 
 
3.2.2 Neuropsychological assessment 
For the assessment of cognitive functioning we composed a battery of tests supposed to measure 
those cognitive functions that were found to be impaired in schizophrenic patients, and are 
presumably affected in patients with persistent AVH as well (Nuechterlein et al., 2004; 
Nuechterlein et al., 2008). These are attention (Reichenberg, 2010; van Erp et al., 2015), 
executive control processes including problem solving skills and flexibility (Neill & Rossell, 
2013), inhibition (Laurenson et al., 2015; Neill & Rossell, 2013), WM (Kern et al., 2011), 
verbal learning (Holmen, Juuhl-Langseth, Thormodsen, Melle, & Rund, 2010; Nehra, Grover, 
Sharma, Sharma, & Kate, 2016), visual learning (Holmen et al., 2010), as well as processing 
speed (Kern et al., 2011; Reichenberg, 2010; van Erp et al., 2015).  
Thus, the cognitive domains assessed in this study included 1. attention, 2. inhibition, 3. 
learning and memory, 4. verbal and spatial WM, 5. executive function, and 6. processing speed 
being assessed indirectly via reaction times.  
The neuropsychological test battery included the following standardized tests: computerized 
tests for alertness, divided attention, and inhibition from the ‘Test for Attentional Performance’ 
(TAP), ‘California Verbal Learning Test’ (CVLT), digit span and Corsi block forward and 
backward, and a computerized version of the ‘Wisconsin Card Sorting Test’ (WCST). In 
addition, fluid intelligence and thereby premorbid intelligence was estimated using the ‘subtest 
3’ of the ‘Leistungsprüfsystem’.  
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The computer-based tests from the test battery were run on a computer using Windows 7 
Professional as operating system. They were presented on a 15-inch computer screen and 4:3 
screen format. Screen resolution was 1280x1024. Participants were seated approximately 50-
60cm in front of the screen which was placed on eye-level. 
 
Leistungsprüfsystem 
The Leistungsprüfsystem (LPS; English translation: performance test system) is an intelligence 
test and was developed by Wolfgang Horn (Horn, 1983). The subtest 3: Recognition of (ir-
)regularities in geometric figures, version A1, was used as estimation of premorbid intelligence. 
It is a paper-and-pencil test and based on Raven’s ‘Progressive Matrices’ (Raven, 1938). The 
test consists of 40 lines and thus 40 trials with each eight symbols in a row. Participants are 
instructed to find the one symbol that does not fit to the rest of the symbols in the row. Trials 
are of increasing difficulty level. The time limit is set to 10min. The evaluation is carried out 
by means of a template with number of correctly identified stimuli as chosen measurement. 
According to the manual, standard scores and percentiles are available for the age groups 9 – 
‘50 and older’. They are based on 100 male and 100 female participants each for the groups up 
to the age of 18; thereafter there were not enough female participants available (Horn, 1983). 
Test-retest reliability for the overall score is found to be excellent (r=0.95), however, subtest 3 
in itself is not that reliable (r=0.66), indicating considerable learning success with repeated 
tests. In contrast, split-half reliability is found to be 0.90. Regarding validity, subtest 3 is mainly 
correlated with mathematics and not necessarily with general school performance. 
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Test for Attentional Performance (TAP) 
To measure attention two tests from the ‘Test for Attentional Performance’ (TAP; Zimmermann 
& Fimm, 1995) were selected: ‘Alertness’ and ‘Divided Attention’. Inhibition was measured 
with the ‘Go/NoGo’ task from the same test battery.  
 
Alertness. Alertness means the ability to maintain in a vigilant state over time that allows 
responding quickly and adequately to a given challenge and thus represents a basic function of 
attention. The alertness task used during the neuropsychological assessment resembles the one 
used during fMRI scanning and is thus already described in the according chapter. In short, 
alertness is measured with reactions times during two conditions: As a start, the reaction time 
is simply assessed as button press after the presentation of an oblique cross that is presented at 
randomly varying intervals (i.e., intrinsic alertness, IA). In the second condition, an audio 
warning tone is preceding the cross (i.e., phasic arousal, PA). Here, the test consists of four 
blocks with 20 trials each and is performed according to an experimental ABBA design: IA(1) 
– PA(1) – PA(2) – IA(2). Before each block, two exercise trials are presented that are not 
included in the final evaluation. The time required for the test is approximately 4min 30s. The 
difference between the two reaction times (the auditory warning condition was subtracted from 
the condition without sound stimulus) is used as measure for alertness. 
 
Divided Attention. Divided attention refers to the ability to attend to multiple requirements at 
the same time. For the current study, implementation form I (German: ‘Durchführungsform I’) 
was chosen from the TAP (Zimmermann & Fimm, 1995) test battery in order to measure 
divided attention. It is measured with a dual task that demands the simultaneous handling of 
two tasks, one visual and one auditory. The visual task asks participants to monitor a screen 
showing a square field of 4x4 positions. At these 16 positions, 6-8 small crosses appear on each 
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trial. The visual stimuli switch positions at a fixed rhythm of 2s. A button press is required if 
four adjacent crosses form a square. Simultaneously and synchronously to the change of 
position of the crosses, participants are presented with two different sounds – a high-pitched 
tone and a low tone. Presentation of auditory stimuli is 1s and 433ms. For the auditory modality, 
a button press is required when two consecutive tones are similar. For the visual modality, 100 
stimuli are presented of which 17 require a response and thus are critical. The number of 
auditory stimuli is 200, including 16 targets. Total execution time is 3min and 25s. Hits and 
misses are recorded. D’prime as sensitivity index for the false-alarm and hit rate over both 
conditions, calculated using the log-linear correction (Hautus, 1995) was used as measure for 
divided attention. 
 
Inhibition. In order to assess inhibition the subtest ‘Go/NoGo’ implementation form ‘1 out of 
2’ was selected from the TAP (Zimmermann & Fimm, 1995). The task asks participants to 
focus attention on the predictable appearance of a stimulus that then requires a selective 
response. More specific, the Go/NoGo task requires participants to only respond to one critical 
stimulus in a task with two stimuli. Two stimuli, a plus (‘+’) and an oblique cross (‘x’), are 
presented in white on the middle of a black screen in an alternating sequence. Participants are 
instructed to only respond to the oblique cross with a button press as soon as possible. The 
presentation of stimuli is short (200ms) to provoke a quick response. In total, 20 critical and 20 
non-critical stimuli are presented. The task takes approximately 2min. Corresponding hits and 
misses are recorded. Again, log-linear corrected d’prime was used as measurement of 
inhibition. 
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Digit span task 
In order to measure verbal WM the digit span task adapted from the Wechsler Memory Scale 
(WMS-R, Wechsler, 2000) was used. The digits used are not the same as in the original version. 
However, since the test results were used as raw values to compare them with those of the 
current sample and not with those from the standard sample of the manual there should be no 
consideration regarding their use. 
Participants are presented with a sequence of numbers increasing in length, and thus in 
difficulty level, every two trials. The experimenter reads the sequence at a speed of 
approximately one digit per second. First, participants are instructed to repeat the numbers in 
the same order as read by the experimenter (forward-condition). Subsequently, the task is to 
repeat the numbers in reversed order (backward-condition). In the beginning, the sequence 
entails three digits, both, in the forward and the backward condition. There are two trials per 
difficulty level. At least one proper response is required to continue with the next longer 
sequence adding one digit at a time. The task is aborted as soon as the participant fails to repeat 
at least one of the two trials during the presentation of the same string length correctly. There 
is no time constriction. The number of correct trials before discontinuation (range: 0-12) for 
both, forward and backward condition, were used as measurement for verbal WM. The forward 
condition is thought to test maintenance of information, whereas the backward condition 
requires both maintenance and further manipulation (Wolf & Walter, 2008) and thus is 
considered to measure a slightly different aspect of WM. 
 
Block tapping test 
Visuo-spatial WM was assessed using an adaptation from the Corsi block, also known as block 
tapping test or spatial span task (Corsi, 1972), found in the WMS-R (Wechsler, 2000). The test 
material consists of a wooden board (approx. 22 x 27cm) with spatially similar separated nine 
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wooden blocks. Participants watch the experimenter tap a sequence of blocks and are asked – 
analogous to the digit span – to first, mimic the shown pattern (forward-condition) and then to 
repeat the pattern in reversed order (backward-condition). The blocks are numbered on the 
experimenter’s side of the board, invisible to the participant, to ease the tapping of fixed 
sequences as well as the recording of the participant’s performance. During any particular 
tapping sequence each block is tapped only once with a speed one block per second. The task 
starts with a small number of blocks, i.e., three, gradually increasing in length, adding one block 
every two trials, until the participant’s performance suffers. This is the case when two 
consecutive errors occur within a sequence of the same block length. There is no time restriction 
on the test. Parallel to the digit span task, the number of correct responses (range: 0-12) is used 
for analysis. 
Standardization for the WMS-R including both tasks, digit span and block span, was performed 
in 1996-97 with 210 participants between the ages 15-74 years (Wechsler, 2000). Demographic 
variables were based on the statistical yearbook for Germany in 1995. Test-retest reliability for 
the digit span task scores r=0.83 and r=0.60 for block span. A review on WM span tasks in 
general comes to the conclusion that these “ show considerable construct validity insofar as 
they predict performance on a wide array of tasks for which control of attention and thought 
are important” (Conway et al., 2005). 
 
California Verbal Learning Test (CVLT) 
The California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) version 1 
was used as an off-line measurement of verbal learning and memory. Participants are presented 
orally with 16 words from four categories (fish, vegetables, kitchenware, and clothing) that are 
read to them by the experimenter one by one every second. Participants are unaware of the 
number of stimuli and their categories. After presentation, participants are asked to repeat the 
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words they recall. The same procedure is applied five times, every time presenting the same 16 
words in the same order. This is followed by a memory test after an interfering word sequence 
and, again, after a delay of about 20 minutes. Total duration including the 20min waiting period 
equals approximately 30-40min without time restrictions for the individual rounds. The sum of 
words recalled after five consecutively repeated presentations of the same 16 words was used 
as measure of verbal learning (range 0-80).  
The odd-even reliability of the CVLT was calculated to be 0.96 while the test-retest reliability 
after 9 months gave a value of 0.60. Regarding validity, the correlation between the sum score 
of the CVLT and the subtest logical memory from the Wechsler-Memory-Scale-Revised was 
calculated to be 0.53. Standardization was achieved with 303 participants without neurological 
disorder for the age range 20-60 years. Corrections for age, gender, and education were made 
where needed (Testzentrale, n.d.). 
 
Wisconsin Card Sorting Test (WCST) 
The Wisconsin Card Sorting Test (WCST) in its computerized form (Loong, 1989) was chosen 
as a measurement of executive functioning as it is a well-known instrument and most frequently 
used in schizophrenia research. It was run with the help of DOSBox Version 0.74 
(www.dosbox.com), a free DOS emulator, in full screen mode.  
The WCST is composed of response cards that are presented one by one and four stimulus cards 
that are placed side by side. These stimulus cards show one red triangle, two green stars, three 
yellow crosses, and four blue circles, respectively. The WCST requires the participant to match 
the response cards displaying various figures to the stimulus cards by a certain sorting principle, 
i.e., color, form, or number. This is done by striking the corresponding number on the keyboard 
(1-4). The participant is, however, not told how to match though he receives feedback on the 
correctness of his matches on every single trial. The feedback is given in the form of an auditory 
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response (high tone for correct and low tone for incorrect) as well a visual response (‘right’ or 
‘wrong’ flashes on the screen). The matching rule is switched after 10 correct responses in a 
row. Every sorting principle is repeated two times in a predefined order that looks as follows: 
color(1) – form(1) – number(1) – color(2) – form(2) – number(2). The test has a maximum of 
128 trials and ends when six sequences of 10 correct responses have been achieved or when the 
maximum of trials has been reached. It lasts approx. 20-30mins. 
Normative data is available for the manual version of the WCST (Heaton, Chelune, Talley, 
Kay, & Curtiss, 1993) which is based on 899 subjects. According to the manual, the (manual) 
WCST has excellent interrater reliability (r=.83-1.00) and research support for its construct 
validity as a measurement of executive functioning. However, a few findings should be taken 
into consideration when using the WCST: First, a study conducted to compare the manual and 
computerized version found significantly different variances from the manual version. This 
means there is a need for validation and normative (Feldstein et al., 1999). Therefore, 
interpretation of the computerized version should be done with caution. Second, it should be 
noted that performance on the WCST does not purely measure executive functioning but 
reflects a variety of cognitive functions (Keefe & Harvey, 2012). Classically, performance on 
the WCST is seen as measure of abstract thinking and problem-solving as well as the ability to 
effectively change problem-solving strategies within the specific context and thus as a measure 
of cognitive flexibility (Wolf & Walter, 2008). It has been shown to be sensitive to generalized 
brain damage, i.e., frontal-lobe damage, as well as schizophrenia specific aberrant performance 
(Feldstein et al., 1999). Nevertheless, the percentage of conceptual level of responses was used 
as a measurement of executive functioning as it is thought to best assess insight into task 
principles. It is defined as ‘consecutive correct responses occurring in runs of three or more’ 
(Heaton et al., 1993). Note, however, that all performance scores of the computerized version 
must be treated with caution as is explained above. 
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3.2.3 Psychiatric interview 
Whereas fMRI scan and neuropsychological assessment was realized by the author herself the 
psychiatric interview was conducted by an experienced psychiatrist (Dr. Katharina M. Kubera, 
Dr. Dusan Hirjak, or Dr. Falk Mancke). It consisted of both, self-rating questionnaires to be 
filled out by the participant as well as interview assessment tools that were filled out by the 
psychiatrist after a thorough interview and clinical observation. The measurement tools are 
presented thematically sorted. 
 
Brief Psychiatric Rating Scale (BPRS) 
The BPRS (Overall & Gorham, 1962) is an observer-rating assessment tool that is based on a 
clinical interview and is thought to be filled out afterwards. It was developed mainly for the use 
of efficiently evaluating symptom change in psychiatric patients for the previous week (Overall 
& Gorham, 1962). It takes approximately 20 minutes and consists of 18 items that are rated on 
a 7-point scale ranging from ‘non-existent’ to ‘extremely strong’: 1=absent, 2=minimal, 
3=mild, 4=moderate, 5=moderately strong, 6=severe, and 7=extremely severe. Each item was 
developed based on previous research to assess patients’ symptomatology in a relatively 
discrete symptom complex and is accompanied by a detailed description to facilitate 
administration. In addition to the total value which can be regarded as the global extent of 
pathology (total score range 18-126), a five factor structure was suggested for subjects with 
diagnosis of schizophrenia (Guy, Cleary, & Bonato, 1975): Four items each form the scales of 
anxiety/depression (4-28), anergy (4-28), and thought disturbance (4-28), respectively, and 
three items each are necessary for the scales of activation (3-21), and hostility/suspiciousness 
(3-21). However, recent research findings imply that these subscales might not be quite valid 
(Lachar et al., 2001; Shafer, Dazzi, & Ventura, 2017) and suggest different factors, e.g., 
resistance, positive symptoms, negative symptoms, and psychological discomfort. According 
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to Overall and Gorham, the administration of the BPRS demands a certain level of training. 
Then, inter-rater reliabilities between 0.56 (for item 6: tension) and 0.87 (for item 12: 
hallucinations, and item 5: guilt feelings) for the individual items may be achieved.  
 
Positive and Negative Syndrome Scale (PANSS) 
The PANSS was developed by Kay, Fiszbein, and Opler (1987) as a standardized measurement 
for multiple psychotic symptoms. It is a 30-item, 7-point rating psychiatric instrument for the 
use of clinical interview which can also be answered by reports of primary care staff or relatives. 
Diagnostic information concern symptoms present during the previous week. Direct questions 
may be complemented by observation of affective, cognitive, interactive, psychomotor, and 
perceptual functions. Each item includes detailed operational definitions for each of the seven 
rating points which represent an increase in severity: 1=absent, 2=minimal, 3=mild, 
4=moderate, 5=moderately strong, 6=severe, and 7=extreme. Four scales can be derived from 
the 30 items measuring positive (score range 7-49) and negative symptoms (7-49), a composite 
score indicating the magnitude of difference and predominance of one of the syndromes (0-42), 
and general psychopathology (16-112). Of the 30 items, seven were chosen to represent the 
positive symptom scale, further seven for the negative symptom scale, and the remaining 16 
form the general psychopathology scale. Administration takes approximately 40-50min, 
Normal distribution of the four scales of the PANSS was demonstrated by a research study of 
101 schizophrenic patients of ages 20-68 ages (Kay et al., 1987). Internal consistency, split-half 
and test-retest reliability were supported as well as its construct and criterion-related validity. 
 
Psychotic Symptom Rating Scale (PSYRATS) 
The PSYRATS (Haddock, McCarron, Tarrier, & Faragher, 1999) is another interview 
assessment tool based on psychotic symptoms experienced during the previous week. It is 
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designed to quantify the severity of delusions and hallucinations in patients with schizophrenia. 
We used the auditory hallucinations subscale, since the major focus was to characterize AVH. 
The item pool of the hallucination subscale taps various symptom indices as frequency, 
duration, loudness, sense of controllability, severity and intensity of distress and disruption by 
hearing voices. A 5-point rating scale is used to rate symptom scores: 0=absent … 4=constant 
voices/very loud/content is very negative and distressing. In addition to a total score (range 0-
44) which represents the general severity of AVH, three subscores based on Haddock et al. 
(1999) and Woodward et al. (2014) were computed. Factor analyses revealed three factors 
constituting of an emotional characteristics factor (0-16) encompassing distressing and negative 
content, a physical characteristics factor (0-12) including descriptions of the voice(s) as well as 
a cognitive factor (0-16) containing assumptions regarding the origin of voices and attributions 
of control. 
A study with six raters each rating the same six patient interviews found the inter-rater 
reliability for the hallucinations subscale to be very high; between r=.79 (item disruption)  and 
r=1.0 (loudness and distress) (Haddock et al., 1999). This finding was validated and expanded 
by Drake, Haddock, Tarrier, Bentall, and Lewis (2007). For the hallucinations subscale, they 
found internal consistency values between 0.63 and 0.76 for each item with the total excluding 
that item. Regarding concurrent validity, they found a significant correlation with the PANSS 
hallucination item (rSp=0.81). 
 
Beliefs About Voices Questionnaire (BAVQ-R) 
The revised BAVQ (Chadwick, Lees, & Birchwood, 2000) is a 35-item, 4-point self-rating 
questionnaire measuring patients’ beliefs concerning AVH as well as their emotional and 
behavioral reactions. The revision was launched to better assess individual differences. That is, 
in contrast to the previous version where participants answered ‘yes’ or ‘no’, all responses are 
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now rated on a 4-point scale: 0=disagree, 1=unsure, 2=agree slightly, and 3=agree strongly. 
Participants are instructed to answer the questionnaire with regard to their experience during 
the previous week. In addition, individuals having AVH who hear more than one voice are 
instructed to complete the questionnaire for their most dominant voice. Evaluation is performed 
for five subscales: malevolence (six items, total score range 0-18), benevolence (six items, 0-
18), omnipotence (six items, 0-18), resistance (nine items, 0-27), and engagement (eight items, 
0-24). 
Overall, the BAVQ-R seems to be a reliable and valid instrument to assess “people's 
relationships with their auditory hallucinations” (Chadwick & Birchwood, 1995; Chadwick et 
al., 2000).  
 
Beck Cognitive Insight Scale (BCIS)  
The BCIS is a self-report instrument to evaluate patients’ self-reflectiveness in their 
interpretations of their experiences (Beck, Baruch, Balter, Steer, & Warman, 2004). The 
questionnaire was constructed to contain two sets of items converging into two subscales: self-
reflectiveness and self-certainty. Subjects are asked to indicate how much they agree with each 
of the 16 items on a 4-point rating scale (0=completely disagree, 1=mildly agree, 2=agree, 
3=completely agree). Besides scores on the two subscales a composite index is calculated by 
subtracting the score for self-certainty from that of the self-reflectiveness scale. The 
questionnaire was used to make sure that patients have enough cognitive insight into their 
illness to participate. As a score of 10 points or higher signifies good cognitive insight an 
appropriate cut-off for that purpose was chosen. 
The BCIS composite index correlates significantly with other scales assessing awareness and 
successfully differentiated between inpatients with psychotic diagnoses from inpatients without 
demonstrating good convergent, discriminant, and construct validity (Beck et al., 2004). 
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Edinburgh Handedness Inventory (EHI) 
The EHI is a brief method of assessing handedness for screening purposes. It is a 10-item self-
report measurement where respondents indicate whether they rather perform an act with the 
right or left hand. R is the number of acts performed with the right hand and L is the number of 
acts performed with the left hand. A laterality index is calculated by the difference between R 
and L divided by the total cumulative. A score of 40 or higher indicates right-handedness 
(Oldfield, 1971). 
 
Table 4 represents an overview of the utilized measures and the measured construct. 
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Table 4 
Overview of utilized measures 
 Measured construct 
fMRI  
resting-state neural activation during rest 
alertness task neurofunctional correlates of attention 
n-back task neurofunctional correlates of WM 
Neuropsychological assessment  
LPS – subtest 3 premorbid intelligence 
TAP – alertness retention of an alert state 
TAP – divided attention division of attention upon multiple tasks 
TAP – inhibition inhibition a reflexive response 
digit span task verbal WM  
(backward: manipulation of information) 
block tapping task visuospatial WM  
(backward: manipulation of information) 
California Verbal Learning Task (CVLT) verbal memory 
Wisconsin Card Sorting Test (WCST) executive functioning, cognitive flexibility 
Psychiatric interview  
Brief Psychiatric Rating Scale (BPRS) psychotic symptom severity 
Positive and Negative Syndrome Scale (PANSS) psychotic symptom severity, divided in negative, 
positive, and a general symptom severity index 
Psychotic Symptom Rating Scale (PSYRATS) AVH severity 
Belief About Voices Questionnaire (BAVQ-R) emotional and behavioral reactions to AVH 
Beck Cognitive Insight Scale (BCIS) cognitive insight 
Edinburgh Handedness Inventory (EHI) handedness 
 
 
3.3 Procedure 
Data was collected from April 2014 to February 2017 mainly at the Department of General 
Psychiatry, University Hospital Heidelberg, Germany. Inpatients and patients of a day-care 
hospital were recruited at the above-named clinic as well ‘Klinik für Spezielle Psychiatrie, 
Sozialpsychiatrie und Psychotherapie, Bürgerhospital Stuttgart’. Healthy control subjects were 
recruited via advertisement in a local newspaper and social media as well as recruitment flyers. 
In addition, outpatients were recruited via assigning psychiatrists and psychotherapists as well 
as a speech at the local self-help group. 
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After providing informed consent participants underwent a cross-sectional assessment of 
cognition, psychopathology, and neuroimaging. Consequently, the study consisted of three 
parts that took place on two or three dates within one week up to a maximum of 8 weeks to 
patient’s stress levels at a minimum. Structural and functional neuroimaging data were 
obtained. Furthermore, participants completed a comprehensive cognitive test battery. In 
addition, participants were asked to answer various questions regarding their symptoms, in the 
form of a semi-structured psychiatric interview as well as self-report questionnaires. Each of 
the three parts took approximately one hour for completion. Independent thereof, all 
participants being inpatients received treatment as usual, which consisted of pharmacotherapy 
in combination with cognitive-behavioral treatment, including both individual and group 
sessions.  
This study was approved by the Ethics Review Committee and was conducted in accordance 
with the Declaration of Helsinki. 
 
3.4 Data Analysis 
As the current thesis was part of a larger project, not all measures and variables were taken into 
account in the statistical analyses. They were chosen thoroughly based on their purpose in 
helping to answer the postulated research questions of interest. As a reminder, the current thesis 
focuses on (1) potential group differences in neural activation patterns. Furthermore, it wants 
to correlate AVH-specific neural correlates with (2) test performance on-line, i.e., in the MRI 
scanner, with (3) neuropsychological test performance as well as with (4) specific 
psychopathology.  
Before data analysis, data cleaning and preprocessing of the MRI data was performed. As 
described in the sample description, data cleaning involved the exclusion of participants for 
whom the diagnosis of schizophrenia could not be confirmed during hospital stay, for whom 
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the inclusion criteria for one of the two patient groups could not be confirmed, with known 
difficulties during the completion of the tests and thus insufficient complete test results. 
 
3.4.1 Psychometric and behavioral data 
IBM SPSS Statistics 24 (IBM Corp., 2013) was used for statistical analyses. Raw test scores 
were used for most variables, except for the divided attention as well as the inhibition task, 
where the false-alarm and hit rate were first calculated and then transformed into d’prime as 
sensitivity index using the log-linear correction (Hautus, 1995). Furthermore, for the alertness 
task, a composite score was calculated by subtracting the reaction time on the condition with 
preceding warning tone from the no-warning tone condition. An analogous procedure was 
carried out to calculate an average reaction time for the n-back task (0-back subtracted from 2-
back). 
 
Testing the assumptions 
Prior to actual statistical analyses of the specific hypotheses, data was screened regarding the 
fulfillment of the assumptions given by the chosen statistical method.  
According to the central limit theorem in big samples, usually defined as greater 30, the sample 
distribution will take the shape of a normal distribution regardless of the underlying distribution 
in the population from which the sample was drawn (Field, 2009). However, the present sample 
is smaller than the advised n=30. Therefore, normal distribution cannot be assumed and needs 
to be tested. For testing the assumptions I followed the guideline on exploring assumptions 
described in Field’s ‘Discovering Statistics using SPSS’ (2009). 
 
Testing for normal distribution. As the planned analysis involved comparing groups, the 
distribution in each group, i.e. pAVH, nAVH, and HC was tested regarding normality. The 
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Kolmogorov-Smirnov test was used for that purpose with the suggested critical p-value of 
p<.05 (Field, 2009). The results are presented in Table 5. Note, several variables were 
significant which means that the distribution deviates from a normal distribution. 
 
Table 5 
Test of normal distribution 
 Group; D (p value) 
Variable pAVH nAVH HC 
Test performance on-line 
   
alertness, RT composite .146 (ns) .165 (ns) .116 (ns) 
alertness, FN rate .417 (.000) .240 (ns) .263 (.002) 
n-back, RT composite .173 (ns) .234 (ns) .212 (.031) 
n-back, FN .190 (ns) .262 (.023) .281 (.001) 
n-back, FP  .195 (ns) .308 (.003) .203 (.049) 
Test performance off-line 
   
CVLT, sum .217 (ns) .135 (ns) .192 (ns) 
digit span forward .295 (.002) .206 (ns) .222 (.019) 
digit span backward .148 (ns) .214 (ns) .109 (ns) 
block span forward .156 (ns) .195 (ns) .142 (ns) 
block span backward .191 (ns) .317 (.002) .159 (ns) 
WCST, conceptual lvl .207 (ns) .118 (.023) .253 (.003) 
alertness, composite .199 (ns) .244 (.046) .167 (ns) 
divided attention, d‘prime .138 (ns) .248 (.039) .127 (ns) 
Inhibition, d‘prime .252 (.016) .165 (ns) .256 (.003) 
Psychopathological scores 
   
PSYRATS, total .207 (ns) - - 
PSYRATS, emotional .180 (ns) - - 
PSYRATS, cognitive .214 (ns) - - 
PSYRATS, physical .177 (ns) - - 
Note. D= Kolmogorov-Smirnov test statistic, RT=reaction time, FN=false negative, CVLT=California Vernal 
Learning Test, WCST=Wisconsin Card Sorting Test, conceptual lvl=conceptual level of response score, 
PSYRATS=Psychotic Symptom Rating Scale, ns=non-significant. 
 
Testing for homogeneity of variance. In order to test for homogeneity of variance the 
untransformed Levene’s test was used with a threshold of p<.05. The documented test results 
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in Table 6 are based on the mean as suggested by Field (2009). Significance indicates different 
variances. In sum, the assumption of homogeneity of variances has been violated for some 
variables. 
 
Table 6 
Test of homogeneity of variance 
Variable F  df1 df2 p value 
Test performance on-line 
    
alertness, RT composite .633 2 41 ns 
alertness, FN rate 2.166 2 41 ns 
n-back, RT composite 1.589 2 41 ns 
n-back, FN 1.686 2 41 ns 
n-back, FP 2.778 2 41 ns 
Test performance off-line 
    
CVLT, sum 5.104 2 41 .010 
digit span forward .463 2 41 ns 
digit span backward 2.328 2 41 ns 
block span forward 2.258 2 41 ns 
block span backward 5.295 2 41 .009 
WCST, conceptual lvl 3.810 2 41 .030 
alertness, composite .533 2 41 ns 
divided attention, d‘prime 2.946 2 41 .000 
Inhibition, d‘prime .516 2 41 ns 
Psychopathological scores 
    
PSYRATS, total * 
   
PSYRATS, emotional * 
   
PSYRATS, cognitive * 
   
PSYRATS, physical * 
   
Note. The asterisk indicates an error message by SPSS that there are not enough unique spread/level pairs to 
compute the Levene statistic. 
 
Outliers 
Potential outliers, i.e., extreme or unusual values that deviate from the rest of the data, were 
identified for by visual inspection using boxplot graphs. Potential outliers were suspected for 
the variables digit span forward, WCST, alertness, divided attention, and inhibition. The 
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observed suspected outlier values were inspected regarding correctness and meaningfulness as 
they may indicate bad data, e.g., incorrect data. Outlying values were not found to be erroneous; 
however, one participant from the healthy control group stood out as he/she produced outlying 
test results on multiple variables, suggesting exceptional poor performance or little motivation. 
As the chosen non-parametric test is insensitive to outliers because it works on the principle of 
ranking the data (Field, 2009) it was not removed. The remaining outliers were considered ‘real 
observations’ and random variation from the given sample.  
 
Hypothesis testing 
The data was screened for violation of assumptions prior to analysis. As mentioned above, the 
assumptions for parametric tests were partially violated. This concerns the analyses of two of 
the four hypotheses. Transformation of data was taken into consideration but was decided 
against as “the payoff of normalizing transformations in terms of more valid probability 
statements is low, and they are seldom considered to be worth the effort” (Glass, Peckham, & 
Sanders, 1972). Instead, non-parametric tests, the Kruskal-Wallis test, the Mann-Whitney U 
test as well as Spearman’s correlation, were conducted where necessary. Non-parametric tests 
are based on ranks or medians instead of means. Both, ranks and medians are not affected by 
extreme values and as such are more robust to outlier values in comparison to means (Scibilia, 
2015). For the normal-distributed data, parametric tests were chosen, i.e. Pearson’s correlation 
and analysis of variance: ANOVA. Where applicable, the significance level was corrected for 
multiple comparisons according to the Benjamini-Hochberg approach (Benjamini & Hochberg, 
1995) for false discovery rate (FDR). The Excel-spreadsheet provided by McDonald (2014) 
was used for this purpose with a FDR of .05. 
A group comparison revealed that the two patient groups differed on global symptom severity, 
in specific on positive symptomatology. However, this difference was considered intrinsic to 
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the grouping process as patients with AVH are considered to be more affected than patients 
without AVH, experiencing higher levels of distress and functional disability (Hubl et al., 
2008). Therefore, no analysis of covariance was carried out. 
 
3.4.2 Neuroimaging data 
Data Analysis of neuroimaging data was carried out under supervision of Dr. Dipl.-Biol. Mike 
Michael Schmitgen, 75% estimated own contribution. The analysis of neuroimaging data was 
performed using the Statistical Parametric Mapping 8 (SPM8, r6313; Wellcome Trust Centre 
for Neuroimaging) software package implemented in MATLAB R2015a (MathWorks). 
Neuronal structures were identified and masks created using the Automated Anatomical 
Labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002) from the WFU PickAtlas Tool (Maldjian, 
Laurienti, & Burdette, 2004; Maldjian, Laurienti, Kraft, & Burdette, 2003) for SPM. 
Furthermore, the MarsBaR (version 0.44, MARSeille Boîte À Région d’Intérêt; Brett, Anton, 
Valabregue, & Poline, 2002) toolbox for SPM was used to extract mean activation of 
anatomical regions of interest (ROI) identified by the second level analyses.  
 
Preprocessing 
Prior to data preprocessing, for the alertness task the first eight and for the n-back task the first 
five images were discarded as ‘dummy scans’ to account for MRI equilibration effects. 
Furthermore, to improve reliability of normalization, the origin of all images was reoriented to 
the anterior commissure.  
As visual inspection demonstrated significant motion and ghosting artifacts in 13 subjects, it 
was decided to use the ArtRepair Version 5b toolbox (Mazaika, Hoeft, Glover, & Reiss, 2009; 
Mazaika, Whitfield-Gabrieli, & Reiss, 2007; Mazaika, Whitfield, & Cooper, 2005) along with 
standard SPM routines. The ArtRepair software is a motion adjustment algorithm that is 
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supposedly able to correct for rapid motion and bad volumes (Artifact Repair), bad slices (Slice 
Repair), residual errors that occur after realignment (Motion Regress) and voxel-wise noisy 
time series (Despike and Filter). Its functions can be recognized by the prefix "art_".  
In specific, the function art_slice was applied with a threshold modifier of 10 to repair bad slices 
and voxel spike noise. After performing a slice time correction, data was corrected for head 
movement over the time course of the images using realignment, i.e., an approximation to an 
average image, and art_motionregress, i.e., reduction of the realignment residuals. Participants 
should not have more than 3mm maximum displacement in x, y or z and 3° of angular motion. 
Moreover, art_global was applied to the realigned scans to detect and repair large scan-to-scan 
motion. Then, to enable group analysis, functional images were coregistered to the subject’s 
structural image and spatially normalized to the SPM 8 standard EPI template (voxel size: 
2x2x2mm). Finally, the normalized images were smoothed with a 9mm full width at half 
maximum Gaussian kernel. 
After preprocessing, 7 data sets had to be discarded for the alertness paradigm due to 
uncorrectable MRI ghosting artifacts (6 for the n-back paradigm) and 5 (4) due to movement 
artifacts. Another 5 participants had to be excluded due to left-handedness. Thus, 40 data sets 
were included in the further data analysis for the alertness task and 44 for the n-back task.  
 
First level analysis 
A first level analysis was conducted using SPM8. This was done without the realignment 
parameter as Art Repair routines were used for preprocessing. Thereafter, Art Redo was run 
with the existing SPM.mat files, i.e., the first level was repeated with the repaired data. In order 
to perform a ‘sanity check’ on the individual level (referring to the plausibility of the effect with 
respect to the expected activations, see hypotheses in chapter 2.4), the statistical thresholds for 
these analyses were set at p<0.05, FWE-corrected.  
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For the alertness task, the contrast condition with preceding warning tone (‘Xsound’) vs. 
without warning tone (‘X’) was chosen as contrast of interest. Five participants were chosen at 
random for visual inspection. Statistical analysis and visual inspection of the contrast 
Xsound>X in healthy control subjects revealed a significant activation in the left as well as right 
STG. That is, healthy individuals show more activation in the STG when confronted with an 
auditory signal in comparison to the absence of that beep tone. The STG comprises the primary 
auditory cortex as well as Wernicke’s area and thus necessarily plays an important role in the 
sensation of sound, speech perception and comprehension (Saffran, 2002; Zevin, 2009).  
For the n-back task, the contrast 2-back>0-back was analyzed. Visual inspection in healthy 
individuals revealed a much broader and more diverse neural activation than that of the alertness 
paradigm. The largest and most prominent clusters were identified using the Anatomy toolbox 
(Eickhoff et al., 2005). Activation was found in the left as well as right middle frontal gyrus, 
the left angular gyrus, and left as well as right cerebellum, but also in the left precuneus, the 
left inferior parietal lobule, the right inferior and superior parietal lobule, and the left as well as 
right superior frontal gyrus. The n-back activation pattern includes several brain regions that 
are well described in the literature as associated with language (Motelow & Blumenfeld, 2014), 
attention (Vossel, Geng, & Fink, 2014), and visual as well as verbal WM (Na et al., 2000; 
Tomlinson, Davis, Morgan, & Bracewell, 2014). 
 
Second level and region of interest analysis 
On the second level, neural activation patterns between the three groups, pAVH, nAVH, and 
HC were compared using an ANOVA. Four covariates were entered into the analysis as these 
variables have been shown to influence functional brain activation, i.e., age and gender 
(Takahashi, Ishii, Kakigi, & Yokoyama, 2011), education (Posner & Rothbart, 2005), and 
chlorpromazine equivalents (CPZ, Nejad, Ebdrup, Glenthoj, & Siebner, 2012). Analyses of 
87 
covariance (ANCOVA) were carried out on the repaired first level data following up on the 
previously defined contrasts: Xsound>X (alertness task) and 2-back>0-back (n-back task). 
The ROI analysis was performed following the online-guideline ‘MarsBar: step-by-step 
instructions to extracting region of interest data’ (Grahn, n.d.) using the masks previously 
identified and created by the AAL atlas (Tzourio-Mazoyer et al., 2002) for SPM. The obtained 
activation parameter estimates were entered into the SPSS data table to perform correlational 
analyses between mean local activation in the ROIs and psychometric as well as 
psychopathological measures. 
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4  R e s u l t s  
 
The following chapter presents the results of the present cross-sectional study according to the 
aforementioned research questions. Where applicable, the findings are additionally depicted in 
graphical as well as tabular form. The structure resembles the initially formulated research 
questions and associated hypotheses postulated in chapter 2.4. As a reminder, group, i.e. pAVH, 
nAVH, and HC, is the independent variable in all run analyses. For some analyses, pAVH and 
nAVH were grouped together to form the group of schizophrenic patients (Sz) in general. The 
results are reported at the peak-level with cluster extent (k) and Z-scores. Note that only 
significant cortical and subcortical regions are reported; clusters indicative of cerebrospinal 
fluid (CSF) are considered as artifacts and are not reported. 
 
4.1 Hypothesis 1 
pAVH will show an AVH-related functional neural activation patterns  
For the alertness task, a second-level analysis, an ANCOVA, was run for the contrast 
Xsound>X and the covariates gender, age, education, and CPZ to examine if group has an effect 
on neuronal activation patterns when a preceding warn tone is presented compared to no warn 
tone. It was predicted that pAVH will show a reduced activation in the right fronto-parietal 
attention network comprising the intraparietal sulcus, the inferior parietal lobe, and the dorsal 
premotor cortex as well as in the auditory cortex and SMA. The threshold was set at p<.005 
and cluster size>34.088 (expected number of voxels per cluster, k) following the recommended 
procedure by Lieberman and Cunningham (2009) in order to balance Type I (α) and II (β) errors 
in fMRI research.  
There was no significant effect between the groups. Nevertheless, post-hoc t-contrasts for 
HC>pAVH and nAVH>pAVH as well as the respective inverse were calculated to examine the 
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directed hypothesis of reduced activation in pAVH. The threshold was set at p<.005, 
uncorrected, and k>54.920. The results are summarized in Table 7.  
 
Table 7 
Post-hoc contrasts for neural activation during the alertness paradigm 
Anatomic region Cluster size 
k (voxel) 
equivZ Maximum Voxel Localization 
 (MNI) 
  x y z 
pAVH > HC      
l middle occipital gyrus 138 3.47 -48 -80 10 
  3.47 -38 -92 6 
  2.91 -30 -98 8 
l superior temporal pole 71 3.04 -42 8 -24 
l superior frontal gyrus 71 3.22 -26 60 14 
pAVH > nAVH      
r angular gyrus 208 3.03 44 -70 44 
  3.00 44 -58 54 
  2.94 38 -64 48 
 
For the contrast pAVH>HC, significant activation at the peak-level (p<.005) was found in the 
left middle occipital gyrus (MOG; MNI coordinates: x -48, y -80, z 10), the left superior 
temporal pole (STP; x -42, y 8, z -24) as well as the left superior frontal gyrus (SFG; x -26, y 
60, z 14). The contrast pAVH>nAVH yielded significant activation in the right angular gyrus 
(AG; x 44, y -70, z 44). All other contrasts yielded no significant effects, p>.005. 
In summary, for the alertness task, pAVH demonstrated significantly increased neural 
activation at p<.005 and k>34.088 in the left MOG, the left STP, and the left SFG when 
compared to HC as well as in the right AG when compared to nAVH (see Figure 11). Note, 
these results do not match the predicted right fronto-parietal hypoactivation in pAVH.  
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Figure 11. AVH-related neural activation pattern during the alertness task. 
AVH-related results from the post-hoc contrasts pAVH>HC and pAVH>nAVH for the contrast Xsound>X and 
the covariates gender, age, education, and CPZ (p<.005, uncorrected, spatial extent threshold > 0 voxels for 
illustration purposes). The color bar on the top indicates the intensity of local neural activation measured in Z 
scores from 0=lowest to 6=highest. 
 
For the n-back task, an ANCOVA for the contrast 2-back>0-back was performed with the same 
covariates and thresholds as described above (k>40.142). It was predicted that pAVH show a 
reduced activation compared to both comparison groups in a network commonly associated 
with WM tasks, comprising the DLPFC, the VLPFC, and the inferior parietal lobule. The results 
are summarized in Table 8. 
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Table 8 
Main effect and post-hoc contrasts for neural activation during the n-back paradigm 
Anatomic region Cluster size 
k (voxel) 
equivZ Maximum Voxel Localization 
 (MNI) 
  x y z 
Effect of group      
l Rolandic operculum 867 4.37 -46 -14 16 
  3.97 -40 -8 12 
  3.85 -56 -2 10 
r superior temporal pole 128 3.31 46 -22 -2 
  2.99 46 -12 -6 
  2.84 56 -20 -2 
r middle occipital gyrus 124 3.20 26 -92 10 
  3.12 36 -86 4 
l postcentral gyrus 121 3.26 -42 -22 48 
  3.26 -38 -22 40 
r Rolandic operculum 116 3.08 56 2 12 
  2.87 50 -12 14 
  2.69 52 -24 10 
r cuneus 67 3.54 20 -84 40 
r superior temporal pole 60 3.34 68 -36 18 
pAVH > HC      
r middle cingulate cortex 665 3.47 10 2 38 
  3.20 -2 -2 40 
  3.19 -2 22 38 
r superior temporal pole 354 3.76 46 -22 -2 
  2.87 34 -20 0 
  2.80 52 -24 8 
l superior temporal pole 246 3.60 -56 -18 6 
  2.75 -52 -8 0 
l Rolandic operculum 144 3.21 -46 0 12 
  3.13 -36 -6 10 
r superior temporal pole 131 3.84 68 -36 18 
l postcentral gyrus 104 3.23 -44 -22 50 
  2.92 -38 -22 40 
r supplementary motor area 100 3.26 12 10 64 
r Rolandic operculum 87 3.28 64 8 12 
r postcentral gyrus 79 3.10 56 -8 28 
pAVH > nAVH      
r angular gyrus 190 3.08 46 -62 34 
  2.78 34 -54 26 
l angular gyrus 84 3.09 -44 -52 32 
 
The between-group effect was significant at the peak-level (p<.005) in the left Rolandic 
operculum (ROL; x -46, y -14, z 16), the right STP (x 46, y -22, z -2), the right MOG (x 26, y 
-92, z 10), the left postcentral gyrus (PoCG; x -42, y -22, z 48), the right ROL (x 56, y 2, z 12), 
the right cuneus (CUN; x 20, y -84, z 40), and the right STP (x 68, y -36, z 18). It is shown in 
Figure 12. 
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Figure 12. Spatial pattern of the group effect during the n-back task. 
Results from the second-level analysis for the contrast 2-back>0-back. F-contrast with the covariates gender, age, 
education, and CPZ describing the differences between pAVH, nAVH, and HC (p<.005, uncorrected, spatial extent 
threshold > 0 voxels for illustration purposes). The color bar on the top indicates the intensity of local neural 
activation measured in Z scores from 0=lowest to 16=highest. 
 
Post-hoc t-tests were calculated for the contrasts HC>pAVH, and nAVH>pAVH as well as their 
respective inverse. The threshold was set at p<.005, uncorrected, and cluster size>64.267. The 
results are graphically depicted in Figure 13. For the contrast pAVH>HC, significant neural 
activation was found in the right middle cingulate cortex (mCGC; x 10, y 2, z 38), the right STP 
(x 46, y -22, z -2 & x 68, y -36, z 18), the left STP (x -56, y -18, z 6), the left ROL (x -46, y 0, 
z 12), the left PoCG (x -44, y -22, z 50), the right SMA (x 12, y 10, z 64), the right ROL (x 64, 
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y 8, z 12), and the right PoCG (x 56, y -8, z 28). The contrast pAVH>nAVH yielded a significant 
neural activation in the right and left AG (x 46, y -62, z 34 and x -44, y -52, z 32, respectively). 
 
 Figure 13. AVH-related neural activation pattern during the n-back task. 
AVH-results from the post-hoc contrasts pAVH>HC and pAVH>nAVH for the contrast 2-back>0-back and the 
covariates gender, age, education, and CPZ (p<.005, uncorrected, spatial extent threshold > 0 voxels for illustration 
purposes). The color bar on the top indicates the intensity of local neural activation measured in Z scores from 
0=lowest to 4=highest. 
 
In summary, for the n-back task, pAVH show increased neural activation at p<.005 and 
k>40.142 for the group effect and k>64.267 for post-hoc contrasts in the right mCGC, bilateral 
STP, bilateral ROL, bilateral PoCG, the right SMA, and bilateral AG. However, in contrast to 
the predicted hypoactivation in pAVH neural activation patterns during the n-back task show a 
hyperactivation. Also, the localization does not fully match the predictions. With regard to the 
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predicted activation patterns the inferior parietal areas including PoCG and AG seem to be most 
involved. 
  
Summarizing the above-mentioned findings for both activation paradigms, the alternative 
hypothesis of an AVH-related hypoactivation in neural networks, i.e., the fronto-parietal 
attention network for the alertness task and the WM network for the n-back task, was neither 
supported for the alertness nor for the n-back task. Instead, significantly increased task-
dependent neural activation was found for pAVH when compared with both, nAVH and HC. 
When comparing the results for both paradigms and looking for overlapping brain activation 
areas, it is interesting that there seems to be AVH-related activity in the right AG and left STP. 
The AG has been related to certain aspects of auditory hallucinations before (Alderson-Day et 
al., 2015; Allen et al., 2012) as has the left STP (Jardri et al., 2011). 
Although the found neural activity during the two tasks did not match the predicted activation, 
it was used for further correlational analyses of mean brain activity and test performance in 
neuropsychological tests as well as symptom-specific psychopathology. 
 
4.2 Hypothesis 2  
AVH-related neural activation will be negatively correlated with task performance 
Brain activation coefficients were extracted for both paradigms for the significant neural 
activation in the corresponding brain regions by means of the MarsBaR toolbox and then 
inserted into the SPSS data file for further analysis.  
First, it was tested whether the three groups differed on performance data in the two fMRI 
paradigms, e.g. average reaction time as well as errors (false negatives and false positives). For 
this purpose, a non-parametric Kruskal-Wallis-Test was carried out, one for each paradigm. 
Test performance in the alertness task was not significantly affected by the group; H(2)=1.692, 
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p>.05 for the average reaction time and H(2)=.812, p>.05 for the false negative rate. In 
accordance, group had no effect on n-back task performance; average response time, 
H(2)=2.966, false negative count, H(2)=1.508, and number of false alarms, H(2)=.548, all 
ps>.05. That is, all groups performed equally well. 
To examine the hypothesis of AVH-related neural activation interfering with task performance 
a correlation between brain activation coefficients and on-line task performance was run for the 
pAVH group. As the performance data was partially non-normal for both tasks, i.e., alertness 
and n-back task, a non-parametric Spearman bivariate correlation was performed.  
There was no significant correlation between AVH-related brain activity in the left SFG, the 
left MOG, the left STP as well as the right AG and performance in the alertness task as measured 
with average response time and FN rate, rs between -.192 and .385, all ps(one-tailed)>.05.  
For the n-back task, significant correlations were found between total number of FN and 
activation in the right PoCG (rs=.532, p=.025), between the total number of FP and the left 
PoCG (rs=.458, p=.05), the left ROL (rs=.570, p=.017) as well as the right AG (rs=-.594, 
p=.012), and between the average RT and mean activation in the right SMA (rs=-.530, p=.026). 
All other correlations were found to be non-significant, all ps(one-tailed)>.05. However, when 
FDR-correcting for multiple comparisons none of the correlations previously found to be 
significant retained its significance. Hence, the alternative hypothesis of a relation between 
neural dysfunction on task performance was neither supported for the alertness nor for the n-
back task and has to be declined. 
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4.3 Hypothesis 3  
AVH-related neural activation will be correlated with neuropsychological 
performance off-line3  
Analogous to the approach for the previous hypothesis, it was first determined if there is a group 
effect on cognitive performance. Therefore, a non-parametric Kruskal-Wallis Test was 
performed. The performance on the California Verbal Learning Task (CVLT) was significantly 
affected by grouping, H(2)=12.157, p=.002. For the remaining tests, all groups performed 
equally well, ps>.05. Mann-Whitney U tests (two-tailed) on the comparisons HC>Sz, 
HC>pAVH, and pAVH>nAVH were used to follow up the previous finding. For the contrast 
HC versus Sz, HC performed significantly better on the CVLT (Mdn=65.5), when compared to 
Sz (Mdn=51.5), U=374.0, z=2.301, p=.001, r=.27. To follow-up these findings, the contrast HC 
versus pAVH was analyzed. HC performed significantly better on the CVLT (Mdn=65.5) when 
compared to pAVH (Mdn=51.5), U=473.5, z=2.015, p<.001, r=.30, see Figure 14.  
 
 
                                                 
3 The predicted direction of effect depends on the operationalization of the exact variable measuring 
neuropsychological performance. In accordance with hypothesis 2, correlations between AVH-related mean local 
brain activation and FN rates as well as RT are predicted to be negative, i.e. the lower the neural activation in the 
corresponding network due to it being ‘bound’ by AVH, the higher the FN rates and RT; thus, the poorer the 
performance. In contrast, when test performance is defined in total sum scores the correlation is predicted to be 
positive, i.e., the lower the neural activation, the lower the total score; thus, the poorer the performance. 
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Figure 14. Group differences on verbal learning.  
Schizophrenic patients in general, as indicated by the bracket spanning nAVH and pAVH, as well as pAVH in 
specific scored significantly lower on the sum score of the California Verbal Learning Task (CVLT) when 
compared to HC. With nAVH, there was no significant effect. Group medians are depicted with their 
corresponding 95% confidence interval, calculated from the standard error and critical t-value (Persike, 2012). The 
asterisk indicates significance at the .05 level. 
 
For the remaining contrasts the tests failed to reject the null hypothesis, p>.05 each. When 
applying a FDR-correction, HC still performed significantly better on the CVLT when 
compared to Sz as well as pAVH. To conclude, healthy control subjects not only perform 
significantly better on verbal learning tasks compared to schizophrenic patients in general but 
compared to pAVH patients in specific. 
In order to investigate the hypothesis of a correlation between AVH-related neural activation 
and neuropsychological performance off-line, a non-parametric Spearman correlation was 
performed for the pAVH-group on CVLT performance and mean neural activation during the 
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alertness as well as the n-back task. There was no significant correlation for the pAVH-group 
for the activation in the left SFG, the left MOG, the left STP, and the right AG during the 
alertness task and performance in the CVLT, rS=.320, rS=-.116, rS=-.271, and rS=-.193, 
respectively, all ps(one-tailed)>.05. In contrast, CVLT performance was significantly 
correlated with mean neural activation in the right AG (rs=-.601, p=.011) and the right MOG 
(rs=-.482, p=.041) during the n-back task. All other correlations fell short of significance, p>.05. 
However, after FDR-correction none of the previously significant results retained its 
significance. 
In summary, the alternative hypothesis of a correlation between neural dysfunction and task 
performance during neuropsychological testing must be declined for the alertness as well as for 
the n-back task. The null hypothesis must be retained. 
 
4.4 Hypothesis 4 
AVH-related neural activation will be negatively correlated with symptom-specific 
psychopathology 
As the last hypothesis was operationalized in terms of AVH-specific multidimensional 
psychometric measures, i.e., the auditory hallucinations subscale of the PSYRATS and scores 
on the emotional, physical, and cognitive domains as well as the total score regarding AVH, 
the groups (pAVH versus nAVH) differed per definition on these variables, F(3,22)=141.540, 
p(one-tailed)<.001. As the concerning variable was normally distributed Pearson’s r was 
calculated for the correlation between mean local neural activation and symptom-specific 
psychopathology scores. 
For the alertness task, significant correlations were found between the emotional index score 
and the left MOG (r=.666, p=.006) as well as the right AG (r=.558, p=.024), and between the 
physical index and the left SFG (r=-.559, p=.024). For the n-back task, significant correlations 
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were found between the emotional score and the right AG (r=.475, p=.043), the right mCGC 
(r=.522, p=.028), and the right STP (r=.655, p=.005); between the physical index score and the 
right PoCG (r=.555, p=.02) as well as the right STP (r=.474, p=.043); between the cognitive 
index score and the right CUN (r=-.663, p=.005), and between the total score and the right STP 
(r=.527, p=.026). That is, the right STP correlates with three aspects of the PSYRATS scale, 
the total score, emotional as well as physical index score. However, after FDR-correction none 
of the results remained significant.  
In summary, the alternative hypothesis of a correlation between neural dysfunction and 
symptom-specific psychopathology must be declined for the alertness as well as for the n-back 
task. The null hypothesis must be retained. To sum up, all null hypotheses were retained. 
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5  D i s c u s s i o n  
 
This doctoral thesis was interested in the neural correlates underlying treatment-refractory AVH 
in schizophrenia and its hypothesized relationship with clinical symptom severity and specific 
cognitive processes, i.e., attention and WM. I had set myself the task to answer the question 
whether AVH are associated with different neural activation in known brain areas of interest 
compared to two control groups: one clinical, i.e., non-hallucinating schizophrenic patients, and 
one comprising participants of the healthy population. Furthermore, I tried to elucidate the 
relationship between these functional neural activation patterns and performance on the on-line 
activation paradigms, neuropsychological measures of cognitive functioning, as well as 
psychopathology. 
As a reminder, three groups of participants were enrolled in the study to enable a differentiation 
between the effects of schizophrenia in general and AVH in specific. These groups included 
schizophrenic patients with persistent treatment-refractory auditory verbal hallucinations 
(pAVH), schizophrenic patients without AVH (nAVH), and healthy controls (HC). For some 
analyses, pAVH and nAVH were grouped together to form the group of schizophrenic patients 
(Sz) in general. Four hypotheses were stated and then evaluated regarding confirmatory 
indicators of evidence: 
• Hypothesis 1. Groups will differ in functional neural activation patterns. In specific and in 
accordance with the symptom interference idea, reduced neural activation in hallucinating 
patients when compared with both control groups was hypothesized. 
• Hypothesis 2. AVH-related neural activation will interfere with task performance on-line. 
The direction of correlation was predicted to be negative.  
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• Hypothesis 3. AVH-related neural activation will be correlated with neuropsychological 
performance off-line. Here, the direction of effect depends on the operationalization of the 
exact variable measuring neuropsychological performance off-line. 
• Hypothesis 4. AVH-related neural activation will be negatively correlated with symptom-
specific psychopathology. 
 
5.1 Summary of results 
Regarding the first hypothesis, both fMRI activation paradigms, the alertness task and the n-
back task, lead to significant AVH-related neural activation at p<.005 and cluster size>k 
(expected number of voxels per cluster). During the alertness task, pAVH demonstrated 
significantly increased neural activation at k>34.088 in the left MOG, the left STP, the left SFG 
as well as in the right AG when compared to both, nAVH and HC. These results however do 
not match the predicted reduced activation in the right fronto-parietal network in comparison 
to both control groups. During the n-back task, pAVH showed increased neural activation at 
k>40.142 and k>64.267 in the right mCGC, bilateral STP, bilateral ROL, bilateral PoCG, the 
right SMA, and bilateral AG. However, in contrast to the predicted hypoactivation in pAVH 
when compared to the control groups neural activation patterns during the n-back task show a 
hyperactivation. Also, the localization does not fully match the predictions, except for DLPFC 
and inferior parietal areas. 
Although not matching the previous stated hypotheses with regard to the direction and 
localization of the effect, mean local brain activation was used for further analysis.  
With regard to the second hypothesis, the three groups neither differed in task performance in 
the MRI scanner nor did the neural activation correlate with that performance after FDR-
correction. This held true for both paradigms, the alertness task as well as the n-back task. 
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Regarding the third hypothesis, there was no FDR-correctable correlation between AVH-
related neural dysfunction and task performance during neuropsychological tests for the 
alertness as well as for the n-back task. However, an additionally performed group comparison 
revealed that schizophrenic patients in general and hallucinating individuals in specific 
performed significantly worse on verbal learning when compared to healthy controls. 
Regarding the last hypothesis, hypothesis 4, the correlation between the AVH-related mean 
local activation and symptom-specific psychopathology scores yielded no FDR-correctable 
effects. 
The results are summarized in tabular form in Table 9. 
 
Table 9 
Summary of results 
  
result in addition 
Hypothesis 1 AVH-related neural activation patterns 
  
H0: pAVH=nAVH=HC   
Ha: pAVH<nAVH, HC pAVH>nAVH, HC  
Hypothesis 2 corr(AVH-related neural function,task) 
  
H0: r ≈ 0 retained  
Ha: r < 0  rejected  
Hypothesis 3 corr(AVH-related neural function,neuropsychology) 
  
H0: r ≈ 0 retained  
Ha: r < 0 rejected CVLT:HC>pAVH 
Hypothesis 4 corr(AVH-related neural function,psychopathology) 
  
H0: r ≈ 0 retained  
Ha: r < 0 rejected  
Note. H0=null hypothesis, Ha=alternative hypothesis, r=correlation coefficient; ≈ 0 indicating no correlation and  
< 0 suggesting a negative correlation. 
 
5.2 Discussion of results 
Looking at Table 9, it becomes obvious that none of the initially formulated hypotheses could 
be confirmed with regard to the predicted direction of the effect. The initially formulated 
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hypotheses relied on the symptom interference approach. That is, AVH-related neural 
resources, primarily those who show activation during resting-state, are bound by these 
hallucinations and therefore less available to other mental operations, i.e. task performance. 
Therefore, a decreased neural activation pattern in patients suffering from treatment-refractory 
AVH compared to non-hallucinating schizophrenic patients and healthy control participants 
was predicted. Put differently, the increased resting-state activity is suggested to explain the 
difference to the predicted hypoactivation during task performance. However, significant task-
induced hyperactivation with uniform p<0.005 and k>cluster size, an appropriate approach 
considering the hypotheses and the number of cases, in pAVH when compared to nAVH and 
HC was found for the alertness task as well as the n-back task. In light of the equal performance 
accuracy across all three groups this may point to neural compensation. That is, the neural 
correlates that were formerly thought of as bound by AVH (and therefore not available for task 
demands) might have been available to pAVH after all and thus exhibiting hyperactivation in 
order to match specific task demands. This matches the existing literature on a neural 
compensation hypothesis in schizophrenia showing that patients’ normal performance is often 
associated with a larger neural response during task performance (Swerdlow, 2010). Indeed, 
the current study showed that task-related neural hyperactivation in multiple brain areas 
correlated with normal task performance during the n-back task, although significance did not 
withstand the correction for multiple testing. Quintana et al. (2003) point out that compensatory 
responses can be altered by manipulating specific task demands. Depending on whether these 
can be met by alternate, efficacious and available resources this may result in neural hypo- or 
hyperactivaton. These findings support the notion of successful neural compensation for 
inefficient brain functioning in schizophrenic patients (Swerdlow, 2010). Specifically, an 
extensive literature points to compensatory processes during WM tasks such as the n-back task 
(Callicott et al., 1999; Wolf et al., 2009). In this context, the Yerkes-Dodson curve is often 
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mentioned (Yerkes & Dodson, 1908). It illustrates the U-shaped relation between neural 
activity increasing with task load and difficulty and decreased accuracy and slower reaction 
times. That is, in difficult tasks task performance is best with intermediate neural activity. At 
both, high and low activation, i.a. WM performance is impaired. What at first glance might 
seem as contradictory to the symptom interference hypothesis and its predicted hypoactivation 
can be explained as follows: The compensatory response to task-specific hypo- or 
underactivation is a hyper- or overactivation in potentially higher, less functionally specialized 
network nodes (Crossley et al., 2016). In other words, symptom-interfered hypoactivation in 
task-relevant neural correlates might be observed as long as it cannot be compensated 
sufficiently by hyperactivation in available compensatory networks. 
With respect to the found AVH-related neural hyperactivation (as a reminder: the MOG, the 
left STP, the left SFG, and the right AG for the alertness task as well as the right mCGC, 
bilateral STP, bilateral ROL, bilateral PoCG, the right SMA, and bilateral AG for the n-back 
task) the following can be concluded: most of the brain regions showing AVH-related 
hyperactivation in the current study have been associated with AVH in schizophrenia before, 
thus the results match previous findings. For example, the comprehensive meta-analysis by 
Jardri et al. (2011) noted that AVH are associated with increased activity in fronto-temporal 
areas that are involved in language function including the frontal opcerulum and the STG. 
Furthermore, attenuated activation associated with AVH has been observed in the PoCG (Kuhn 
& Gallinat, 2012), the STG (Kuhn & Gallinat, 2012; Lennox et al., 2000), the STP (Diederen 
et al., 2012), parts of the inferior parietal pole (Diederen et al., 2012), the SMA (Clos, Rottschy, 
Laird, Fox, & Eickhoff, 2014; McGuire et al., 1996) as well as visual areas in the occipital lobe 
(Zhuo et al., 2017). Furthermore, limbic and paralimibic regions, including the cingulate gyrus 
have been demonstrated to show abnormal activation in hallucinating individuals (Silbersweig 
et al., 1995). In addition, the anterior part of the STG has been bilaterally correlated with AVH 
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severity, as has been the left PoCG (Nenadic, Smesny, Schlosser, Sauer, & Gaser, 2010). 
Evidence also suggests a negative correlation between the white matter integrity in the cingulate 
cortex and the severity of hallucinations (Curcic-Blake et al., 2017; Curcic-Blake et al., 2015). 
Moreover, the AG has been related to certain aspects of auditory hallucinations (Alderson-Day 
et al., 2015; Allen et al., 2012). For example, Allen et al. (2012) and Vercammen, Knegtering, 
Bruggeman, and Aleman (2011) correlated loudness of voices with neural activity in bilateral 
AG. In addition, Nenadic et al. (2010) found the left AG to correlate with AVH severity. The 
AG is an interesting finding for two reasons: First, it has been found to show significantly 
increased activity in both tasks. Second, it has not been mentioned in the AVH literature that 
often compared to the other brain regions, thus presenting a so far overlooked but potentially 
promising result.  
The AG lies in the posterior part of the inferior parietal lobule and is commonly considered part 
of the association cortex (Seghier, 2013). In general, the AG is associated with multiple 
functions, e.g., semantic processing, reading and comprehension, memory retrieval, attention, 
and social cognition. Furthermore, it has been related to the DMN as well (Seghier, 2013). 
Accounting for its multiple functions and neural connections, the AG is thought of as cross-
modal integrative hub or, as Walker (1990) put it: the "association area of the association areas" 
(p. 335). According to the Wernicke-Geschwind model for language processing, the AG is 
involved in the connection of visual stimuli with and conversion into its auditory equivalent 
(Wickens, 2009). In other words, it translates visual information to a form accessible by 
Wernicke’s area. This suggestion is supported by its anatomy and structural connections with 
the visual as well as the hearing association cortex (Walker, 1990). Not only that, because of 
its rich connectivity, the AG gives meaning to events, connecting them, based on prior 
expectations and conceptual knowledge (Seghier, 2013). Therefore, the association cortex in 
106 
general (Hoffman, 2007) and the AG in specific (Seghier, 2013) have been associated with 
AVH within the predictive processing framework (PPF) that we encountered in chapter 2.2.3.   
Figure 15 illustrates the AG as connecting hub between bottom-up multisensory inputs and top-
down predictions based on prior knowledge and experiences as well as the sense of agency. It 
works by recurrently exchanging predictions and corresponding prediction errors to minimize 
the prediction error. By integrating this information, the AG improves the probabilistic 
representation of the cause of the received sensory input (Seghier, 2013). The purpose is to 
better understand events in the external world as well as internal mental processes, thereby 
contributing to cognitive processes as diverse as semantic access, retrieval of facts, 
categorization of events, and attention shifting (Figure 15A). Note, the exact role of the AG 
depends on the set of regions it interacts with, as illustrated in Figure 15B.  
The PPF may explain the implication of the AG and its functions in the occurrence and physical 
characteristics of AVH. For instance, semantic processing is a key process in language 
comprehension and reading. Language processing is known to be impaired in schizophrenic 
patients with AVH, i.e. AVH are consistently associated with aberrant functioning of speech 
production (e.g., inferior frontal gyrus including Broca’s area) and language perception areas 
(e.g., STG including Wernicke’s area) (McGuire et al., 1996; Strik, Dierks, Hubl, & Horn, 
2008; Zmigrod et al., 2016). Furthermore, AVH correlate with lower verbal IQ (Seal, Crowe, 
& Cheung, 1997). Likewise, fact retrieval as part of memory function is known to be impaired 
in AVH as is the case for verbal memory (Jardri et al., 2011; Seal et al., 1997), context and 
source memory (Brookwell et al., 2013; Waters, Badcock, Michie, & Maybery, 2006) and WM 
(Aleman, Böcker, Hijman, de Haan, & Kahn, 2003). This has led to the aberrant memory 
processing model of AVH that proposes AVH to be caused by intrusive  
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Figure 15. The function of the AG within the PPF. 
A. The AG as connecting hub between multisensory inputs and predictions based on prior knowledge, learned 
experiences, and the sense of agency. The integration in the AG takes place via the recurrent exchange of 
predictions (blue arrows) and corresponding prediction errors (red arrows) in order to minimize prediction errors 
and to enable cognitive processes such as semantic access, fact retrieval, event categorization, and shifting 
attention. B. The AG in its function as connecting hub receives inputs from different modalities (red arrows) and 
interacts with different subsystems (orange arrows) including action, attention, saliency, and semantics. Blue 
arrows indicate potential other interactions. With kind permission, illustration taken from Seghier (2013), p. 53.  
 
memories (Rossell, 2013). Various authors even hypothesize WM deficits as underlying 
cognitive dysfunction in schizophrenia (Goldman-Rakic, 1994; Keefe & Harvey, 2012). 
However, this is not specific for AVH. The categorization of events, relevant for example for 
understanding the external world (Baillargeon & Wang, 2002), language acquisition (Gentner 
108 
& Boroditsky, 2009) as well as social cognition and memory (Dominey, 2007), have been 
associated with schizophrenic patients experiencing AVH as well (Alderson-Day & 
Fernyhough, 2016; Brown & Kuperberg, 2015). In addition, attentional processes on 
psychological level (Hugdahl et al., 2007) as well as the attentional network on neural level 
have been associated with AVH (Vercammen, de Haan, & Aleman, 2008; Wolf et al., 2011). 
Moreover, bilateral AG is consistently associated with the DMN (Seghier, 2013) that itself has 
been correlated with the experience of AVH (Williamson, 2007). “In the case of the default 
network, the manipulation of conceptual knowledge, the sense of agency, and the retrieval of 
previous experiences (as predictions in Figure 15A) can modulate AG activity even in the 
absence of external sensory inputs“, resulting in the experience of hallucinations without actual 
external sensation (Seghier, 2013, p. 52). 
Following this trail of reasoning and comparing the current neuroimaging results with brain 
regions associated with the PPF, there is substantial overlap (see Figure 16). For instance, neural 
activation was found in part of the cingulate cortex, the anterior part of the STG, the SMA and 
parts of the parietal lobe including the AG and PoCG. However, the specific neural correlates 
do not match fully, i.e. the current study could not demonstrate neural activation in the PFC and 
ACC but in the SFG, MOG, ROL, and CUN. Furthermore, the comparison suggests and 
supports the idea of malfunctioning neural networks instead of isolated brain regions and/or 
structural deviations. 
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Figure 16. Juxtaposition of the found neural activation and the brain areas associated with the PPF 
Comparison between neural correlates associated with the PPF and the current findings. Left. Interacting brain 
regions (arrows illustrate the direction of influence) associated with the PPF thought to be underlying AVH in 
schizophrenia. The dashed blue line illustrates an increase in excitation. With kind permission, illustration taken 
from Curcic-Blake et al. (2017), p. 4; detail. Right. Neural activation of post-hoc t-contrasts for both activation 
paradigms in the pAVH group, the alertness task (red) and n-back task (green). The color bars indicate the intensity 
of local neural activation measured in Z scores from 0=lowest to 4=highest   
 
In summary, there is support for the hypothesis that deviant functioning of the AG may be at 
the core of AVH. That is, AVH in schizophrenia may be seen as resulting from a deficient 
integration of information or aberrant neural connectivity leading to erroneous prediction 
processing. Critically, these issues warrant further investigations. Potential implications and 
recommendations for further research are discussed below in chapter 5.4: Prospect. 
For the remaining hypotheses, none of the results remained significant after FDR-correction 
and thus, the hypotheses had to be declined. These rather unexpected results or non-findings 
may indicate two underlying assumptions: First, opposing the current project’s aim, there is no 
AVH-specific neural activation pattern in patients with schizophrenia and treatment-refractory 
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auditory verbal hallucinations that significantly correlates with neuropsychological 
performance and psychometric test scores. Second, there is a correlation between AVH-related 
functional activity and performance in neuropsychological test performance and 
psychopathology scores but the current project could not demonstrate it fully. That may have 
different reasons that will be discussed in chapter 5.3: Study strengths and limitations. 
A growing body of research literature on AVH points to the second explanation as associations 
between neuroimaging and AVH characteristics as well as neuropsychological test performance 
have been demonstrated repeatedly. For example, Wolf et al. (2011) presented correlations 
between AVH severity and functional connectivity of the left ACC, left STG and right lateral 
prefrontal cortex. Furthermore, Kubera et al. (2014) found an association between AVH 
frequency, duration, and intensity and reduced gray matter volume in medial and inferior 
frontal, insular and bilateral temporal cortical regions. Moreover, Nenadic et al. (2010) pointed 
out that AVH severity seems to be associated with activity in the STP and PoCG.  
In addition to non-confirmed hypotheses, there is a finding that needs to be acknowledged: 
Schizophrenic patients in general and hallucinating individuals in specific performed 
significantly worse on verbal memory when compared to healthy controls. This schizophrenia- 
and AVH-related deficit in verbal memory matches previous research results. Deficits in verbal 
learning and memory have consistently been associated with schizophrenia in general (Holmen 
et al., 2010; Nehra et al., 2016) and auditory hallucinations in specific (Allen et al., 2012). It 
has even been hypothesized that a malfunction of the verbal memory system may be (in part) 
responsible for the involuntary occurrence of AVH (Allen et al., 2012; Jardri et al., 2011) which 
was summarized in the previously mentioned AVH-model of aberrant memory processing. 
Expanding thereupon and bridging to the previous discussion on the PPF perspective, we now 
know that fact retrieval and language processing involve activation of the AG. Remember that 
AG is thought of as connecting hub integrating information. Verbal memory deficits in the 
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CVLT thus may suggest that new stimuli in the form of the presented words are not properly 
integrated, potentially leading to false prediction errors regarding the words to come (Fletcher 
& Frith, 2008). The correlation between CVLT performance and AG activity for both activation 
paradigms supports the notion, although significance did not withstand correction for multiple 
testing. The current study, thus, replicates and confirms earlier findings, thereby supporting the 
importance of verbal memory deficits in the symptom occurrence of hallucinating 
schizophrenic patients. Note, however, although verbal memory deficits were found in an off-
line verbal memory task there was no indication of altered neural function in the hippocampus 
as should be expected if memory function was truly at the core of AVH. 
 
5.3 Study strengths and limitations 
There are strengths and limitations to the present project that need to be acknowledged. 
The most apparent strength of the current project concerns the comparison of three groups 
instead of just two: one group of interest (pAVH) with two comparison groups – one clinical 
(non-hallucinating patients: nAVH) and one composed of individuals of the healthy population 
(HC). This is remarkable since the vast majority of AVH-related research so far has been limited 
to comparisons between pAVH and nAVH or pAVH and healthy controls (Curcic-Blake et al., 
2017). This study design offers the opportunity to distinguish between effects of schizophrenia 
per se and hallucinations in specific. 
Still, there are several limitations to be considered. First, the enrollment process turned out more 
difficult and lengthy than planned. Despite prolongation of the recruitment phase, the desired 
goal of n=25 per group was not reached. Patients suffering from schizophrenia are, per 
definition, suspicious and very often not eager to take part in research. Furthermore, a large 
percentage of affected individuals met exclusion criteria, most often substance abuse or 
dependence as well as lefthandedness (see Figure 7 on page 55). In addition, due to realistic 
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study conditions in a clinical setting, there was an unexpectedly high percentage of drop-outs 
and incomplete data sets due to early discharge. Of 96 patients found eligible for study entry, 
for the n-back task only 26 (23 for the alertness task) were included in the final analysis – 
27.08% (23.96%). The included sample might, thus, be highly selective with the more severely 
affected individuals having refused to participate or dropping out. The fact that patients’ 
performance during the alertness and n-back task did not significantly differ from healthy 
controls further supports the notion of a potential selection bias. Also, the modest sample size 
of the present study may have limited the significance of some of the statistical comparisons 
conducted. Second, although the two patient groups did not differ significantly in antipsychotic 
medication as measured in chlorpromazine equivalents, most of them did receive antipsychotic 
drug treatment during study participation. A potential effect of antipsychotic medication on 
neural activity and/or task performance cannot be fully ruled out. Third, schizophrenic patients 
with and without hallucinations did differ in global symptom severity with hallucinating 
individuals being more severely affected. Baethge, Janner, Gaebel, and Malevani (2017) state 
that “hallucinations are a sign, if not a cause, of greater illness severity. When compared with 
non-hallucinating individuals in either diagnostic group, hallucinators were more affected by 
delusions and by anxiety” (p. 299). This, however, leaves unanswered the question of whether 
the found effects reflect the difference between hallucinating and non-hallucinating patients 
with schizophrenia or whether they might also be accounted for by symptom severity in general. 
Fourth, there was no direct assessment of whether patients hallucinated during the MRI scan or 
not. Instead, AVH were assessed globally before scanning and were treated, as defined by 
inclusion criteria, as treatment-resistant and thus persistent. Fifth, the activation paradigms 
during MRI scanning relied on the button press method which means that it might have 
confounded the associated mean local activation to include the patients preparing and carrying 
out a motor response. However, this was the same for all three groups and, therefore, it should 
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balance out in the further analyses. Sixth, because of the large number of analyses performed, 
the reliability of individual results and specific coefficients must be interpreted with due caution 
due to multiplicity. However, it has been tried to cope therewith by correcting for multiple 
testing using FDR-correction. Note, that the fMRI analyses were exempted from the FDR-
correction following the recommended procedure by Lieberman and Cunningham (2009) to 
balance Type I (false positives) and II (false negatives) errors. It is important to mention that 
(1) recommendations vary (e.g., Benjamini & Hochberg, 1995; Lohmann, Neumann, Mueller, 
& Lepsien, 2008) and that (2) fMRI research and the according results are being critically 
evaluated in an ongoing debate (e.g., Eklund, Nichols, & Knutsson, 2016; Kessler, Angstadt, 
& Sripada, 2017). Additionally, block designs, i.e. the block subtraction methodology has been 
criticized as overlapping brain regions subserving different functions could cancel each other 
out leading to an increase in false negatives (Logothetis, 2008). Furthermore, in his extensive 
overview Logothetis (2008) reminds that neural activity is way more complex than networks 
of neurons lighting up in the fMRI scanner meaning involvement in the task at hand. He goes 
on to explain that the earlier concept of the brain as information processing entity with input-
elaboration-output is oversimplified and does not account for excitation–inhibition networks: 
„The fMRI signal cannot easily differentiate between function-specific processing and 
neuromodulation, between bottom-up and top-down signals, and it may potentially confuse 
excitation and inhibition“ (p. 877, for further information consult the article in question). That 
is, any given neurofunctional correlate resulting from fMRI research may represent a cause, a 
consequence, or neural compensation (Lewis & Gonzalez Burgos, 2008). These results indeed 
may call into question the validity of countless published and current fMRI studies. The extent 
and implication has yet to be fully evaluated. Note, however, that the technology as well as the 
statistical analyses in question are being developed and improved constantly relativizing the 
above-mentioned criqitue. 
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5.4 Prospect 
Based on the current study, its results, strengths, and limitations, there are several 
recommendations that should be addressed in further research.  
First, it is highly questionable whether an externally elicited, task-induced hypo- or 
hyperactivation in any one brain structure may reveal the full complexity of functional 
dynamics associated with symptom occurrence. Furthermore, at this stage of research where 
the intrinsic neuronal baseline of the hallucinating brain prior to extrinsic stimulation is not yet 
fully known, it remains open how results derived from symptom interference studies can be 
appreciated. In order to draw valid conclusions about neuronal interference processes it is 
essential to know which brain areas or -networks are associated with the occurrence of AVH 
prior to stimulation. Therefore, I suggest supplementing the performed analyses with results 
from resting-state as well as functional connectivity analyses based on the data from the current 
project. These additional analyses are beyond the scope of this doctoral thesis and are, therefore, 
planned as follow-up. As the AG and its function as connecting hub appears to be a promising 
site associated with AVH it should be considered as region of interest in the planned resting-
state and task-based functional connectivity analyses.  
Second, with regard to the discussed neural compensatory mechanisms it might be worthwhile 
to consider the effects of task performance in a more differentiated manner. For example, I 
suggest follow-up research to compare subgroups within the pAVH group that differ in their 
task performance. I predict that for the successful, neural compensation plays a more important 
role than for hallucinating patients with poor cognitive performance. In the existing literature, 
subtypes of AVH have been proposed based on different variables such as causal factors, 
phenomenological characteristics, associated cognitive processes, neural correlates, treatment 
response as well as diagnosis (McCarthy-Jones, Thomas, et al., 2014). Especially the last item, 
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i.e. the trandiagnostic character of AVH might be interesting for further research, too. The 
current study focused on hallucinating patients with schizophrenia, but AVH are a 
transnosological phenomenon. AVH might occur in borderline personality disorder, affective 
disorders such as bipolar disorder and posttraumatic stress disorder as well. Therefore, I suggest 
follow-up research to compare phenomenology, neural correlates and task performance for 
AVH between different disorders to better understand common and divergent mechanisms.   
Third, the fact that hallucinating and non-hallucinating schizophrenic patients differ in their 
symptom severity poses another problem that needs to be addressed in further research. On the 
one hand, a greater overall symptom severity associated with hallucinations seems obvious and 
logically understandable and, therefore, disorder immanent. On the other hand, it may cause 
difficulties in the interpretation of results even if statistically controlling for its effect. In order 
to circumvent the aforementioned difficulties and facilitate the interpretation of results there 
are two possible changes to make for further research: One option is to match the patient groups 
on symptom severity. However, if greater illness severity is indeed disease immanent, then the 
sample presented will be biased. Therefore, for a follow-up project, I would like to propose 
adding one more comparison group: healthy participants with a history of AVH that do not 
meet the criteria for schizophrenia-spectrum diagnosis. The comparison between hallucinating 
schizophrenic patients, non-hallucinating patients, non-hallucinating healthy participants, and 
hallucinating healthy individuals would allow dividing the effects of schizophrenia, the 
intensity of their symptom severity, and that of pure hallucinations apart. Furthermore, this 
matches two current developments in the field of schizophrenia and AVH: First, there is an 
ongoing debate about the enormous heterogeneity within schizophrenia suggesting that a 
unitary disorder called schizophrenia does not exist but only a collection of psychological and 
cognitive symptoms (Berrios, Luque, & Villagrán, 2003). Of course, this is in part due the 
nature of descriptive psychopathology and categorial diagnostics. In addition, recent 
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developments are in line with the concept of dimensionality regarding schizophrenia, e.g., the 
elimination of schizophrenia subtypes and introducing schizophrenia-spectrum disorder in 
DSM-5 (American Psychiatric Association, 2013). Second, current research evidence suggests 
that AVH in healthy individuals and schizophrenic patients do not differ significantly in 
functional activity patterns pointing to the aspect of dimensionality (Diederen et al., 2012). 
However, of course, this is also a matter of practicability and the questions remains whether it 
would be manageable, with slight changes in the recruitment process, to enroll a fourth group. 
The same holds true for the aforementioned recommendation of comparing different AVH-
related diagnoses. 
Last but not least, considering potential clinical implications, if it turns out that the AG is indeed 
important in the symptom occurrence of AVH, it may prove to be a promising target site for 
non-invasive brain stimulation techniques, such as tDCS, rTMS, or TBS. At present, tDCS 
mainly focuses on inhibitory stimulation over the left temporo-parietal cortex and excitatory 
stimulation over the left dorsolateral prefrontal cortex (Brunelin et al., 2012) whereas rTMS 
targets the left temporo-parietal cortex (Kubera et al., 2015). However, it needs to be 
acknowledged that any proposed implication, may it be scientific or clinical, is pure speculation. 
That is, the role of the AG in AVH in schizophrenia might be a novel insight, if at all, but needs 
further scientific underpinning to ensure its veracity. At this stage of research it is too early to 
draw any definitive conclusions.  
 
5.5 Overall appraisal 
Summarizing the overall study including its results and their value, this doctoral thesis was 
interested in the neural correlates underlying treatment-refractory AVH in schizophrenia and 
potential associations with clinical symptoms and cognitive processes. AVH are defined as a 
sensory experience of hearing voices in the absence of a corresponding external stimulus with 
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a compelling sense of reality. They are one of the core symptoms of schizophrenia with 50-
80% of patients experiencing AVH (Andreasen & Flaum, 1991). Treatment-refractory AVH, 
i.e., persisting hallucinations despite an adequate treatment which should be sufficient in 
intensity and duration (Berman et al., 1997), cause major distress and affect the lives of patients 
substantially (Vauth & Stieglitz, 2007). To date, the precise neurocognitive and neurobiological 
mechanisms contributing to AVH occurrence are still largely unknown with different studies 
providing inconsistent results. So far, the neuroscientific state of evidence regarding AVH in 
schizophrenic patients points to morphological and functional changes in frontal, temporal and 
parietal regions as well as abnormal network connectivity in the brain. Multiple neuronal 
systems seem to be involved, i.e., language, attention, and executive control. The current study 
was designed as a ‘piece of the puzzle’ to add to the existing literature and answer the question 
whether AVH in schizophrenia are associated with different neural activation in known brain 
areas of interest.  In addition, the relationship between these functional neural activation 
patterns and performance on the on-line activation paradigms, neuropsychological measures of 
cognitive functioning, as well as psychopathology was assessed. Therefore, three groups of 
participants were enrolled in the study to enable a differentiation between the effects of 
schizophrenia in general and AVH in specific. The groups consisted of schizophrenic patients 
with treatment-refractory auditory verbal hallucinations, schizophrenic patients without AVH, 
and participants from the healthy population. For some analyses, hallucinating and non-
hallucinating patients were grouped together to form the group of schizophrenic patients. 
Participants underwent one-time assessment of cognition, psychopathology, and neuroimaging 
on two or three dates each lasting approximately 1-1.5 hours. Structural and functional 
neuroimaging data was acquired. Furthermore, participants completed a cognitive test battery. 
In addition, participants were asked to answer various questions regarding their symptoms, in 
the form of a semi-structured psychiatric interview as well as self-report questionnaires. 
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Independent thereof, all participants being inpatients received treatment as usual, which 
consisted of pharmacotherapy in combination with cognitive-behavioral treatment, including 
both individual and group sessions. 
Four hypotheses were evaluated regarding confirmatory indicators of evidence: (1) Groups will 
differ in functional neural activation patterns. In specific and in accordance with the symptom 
interference idea, reduced neural activation in hallucinating patients when compared with both 
control groups was hypothesized. (2) AVH-related neural activation will interfere with task 
performance on-line. The direction of correlation was predicted to be negative. (3) AVH-related 
neural activation will be correlated with neuropsychological performance off-line. And (4) 
AVH-related neural dysfunction will be negatively correlated with general psychopathology. 
The statistical analyses revealed that none of the initially formulated hypotheses could be 
confirmed with regard to the hypothesized direction of effect. However, both fMRI activation 
paradigms, the alertness task and the n-back task, lead to significant AVH-related neural 
activation at p<.005 and cluster size>k (expected voxels per cluster) in contrast to the predicted 
hypoactivation. Neural activation was mainly demonstrated in fronto-temporo-parietal areas: 
The alertness task demonstrated increased activation in the left MOG, the left STP, the left SFG 
as well as in the right AG; the n-back task in the right mCGC, bilateral STP, bilateral ROL, 
bilateral PoCG, the right SMA, and bilateral AG when compared to both, nAVH and HC. The 
observed hyperactivation was put in the context of existing literature and discussed in the light 
of neural compensation. That is, the neural correlates that were formerly thought of as bound 
by AVH (and therefore not available for task demands) might have been available to pAVH 
after all and thus exhibiting hyperactivation in order to match specific task demands. To 
conclude, symptom interference not only needs to consider neuronal resting state activity but 
also potentially compensatory processes. With regard to the remaining hypotheses on the 
suspected correlation between AVH-related neural dysfunction and task performance during 
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neuropsychological tests as well as specific psychopathology, none of them revealed FDR-
correctable results. However, there was a finding that needs to be acknowledged: An 
additionally performed group comparison revealed that schizophrenic patients in general and 
hallucinating individuals in specific performed significantly worse on verbal learning when 
compared to healthy controls. This fits perfectly in the already existing literature confirming 
that hallucinating patients show a clear deficit in verbal memory and learning. It should be 
mentioned that there was no difference in alertness and WM task. 
The aforementioned results were discussed regarding their potential meaning and implications 
in the light of the predictive processing framework as model for the occurrence of AVH as well 
the clinical implications for the AG as potential target site for brain stimulation. In specific, the 
discussion of results focused on bilateral AG activity as it had been found to be significant in 
both activation paradigms and has not been mentioned in the AVH literature that often 
compared to the other brain regions that are already well established. Thus, the AG might 
present a so far overlooked but potentially promising result. The AG as part of the association 
cortex and in its function as connecting hub is associated with multiple functions, e.g., semantic 
processing, reading and comprehension, memory retrieval, attention, and social cognition. It is 
an important component in the predictive processing framework as presented by Seghier 
(2013). The PPF may explain the implication of the AG and its functions in the occurrence and 
physical characteristics of AVH. Summarizing the discussion, there is support for the 
hypothesis that aberrant functioning of the AG is at the core of AVH. That is, AVH in 
schizophrenia may be seen as resulting from deviant neural connectivity leading to erroneous 
prediction processing.  
However, it needs to be acknowledged that this conclusion as well as any proposed implication, 
may it be scientific or clinical, is rather speculative and needs to be critically reflected and 
examined in the light of further research evidence. It was suggested to make use of additional 
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resting-state and connectivity analyses using the AG and its function as connecting hub as 
region of interest. 
In addition, all speculation aside, please note that the hyperactivation in bilateral AG (and in 
other brain regions) in hallucinating individuals when compared to non-hallucinating patients 
was not corrected for multiple testing but merely a (promising) convention to use in further 
analyses. That is, the role of the AG in auditory verbal hallucinations in schizophrenia might 
be a rather novel insight, but needs further scientific underpinning to ensure its veracity.  
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